dactinomycin has been researched along with etoposide in 524 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 71 (13.55) | 18.7374 |
| 1990's | 162 (30.92) | 18.2507 |
| 2000's | 155 (29.58) | 29.6817 |
| 2010's | 113 (21.56) | 24.3611 |
| 2020's | 23 (4.39) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Barrows, LR; Ireland, CM; Kokoshka, JM | 1 |
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Belinsky, MG; Chen, ZS; Kruh, GD; Shchaveleva, I; Zeng, H | 1 |
| Barone, V; Bolognese, A; Correale, G; La Colla, P; Lavecchia, A; Loddo, R; Manfra, M; Mazzoni, O; Murgioni, C; Novellino, E; Pani, A; Serra, I; Setzu, G; Tramontano, E | 1 |
| Akiyama, S; Baba, M; Furukawa, T; Nitanda, T; Okamoto, M; Sugimoto, Y; Wang, X | 1 |
| Bolognese, A; Correale, G; La Colla, P; Lavecchia, A; Loddo, R; Manfra, M; Mazzoni, O; Novellino, E; Sanna, G | 1 |
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Gibbons, S; Kaatz, GW; Zloh, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bolognese, A; Cerchia, C; Cioce, A; Lavecchia, A; Manfra, M; Pedatella, S | 1 |
| Dombernowsky, P; Nissen, NI | 1 |
| Bakri, YN; Ezzat, A; Pedersen, P | 1 |
| Daxenbichler, G; Helweg, G; Hetzel, H; Judmaier, W; Marth, C; Schwegel, P; Wicke, K; Zeimet, AG | 1 |
| Lurain, JR; Miller, DS; Rademaker, AW; Schink, JC; Singh, DK | 1 |
| Helle, L; Jakobson, M; Järvinen, M; Liippo, K; Nikkanen, V; Ojala, A; Paloheimo, S; Salmi, R; Salomaa, ER; Virén, M | 1 |
| Black, T; Estrada-Aguilar, J; Greenberg, H; Hvizdala, E; Morse, S; Schroer, K; Walling, A | 1 |
| Garrow, GC; Johnson, DH | 1 |
| Green, JA; Husband, DJ | 1 |
| Alonso, C; Climent, MA; Germá, JR; Izquierdo, MA; Ojeda, B; Seguí, MA | 1 |
| Chambers, JT; Chambers, SK; Kohorn, E; McIntosh, S; Schwartz, PE | 1 |
| Calne, R; Clark, PI; Owen, RA; Stebbings, W; Whelan, JS | 1 |
| Gedikoğlu, G; Zülfikar, B | 1 |
| de Dycker, RP; Fechtig, A; Neumann, RL; Schumacher, T; Zajaczkowski, T | 1 |
| Cold, S; Pfeiffer, P; Rose, C | 1 |
| Bagshawe, KD; Begent, RH; Holden, L; Newlands, ES; Rustin, GJ | 1 |
| Miyachi, H; Ohnuma, T; Sekiguchi, S; Takemura, Y | 1 |
| Abratt, RP; du Preez, HM; Kaschula, R | 1 |
| Hagiwara, M; Iinuma, S; Nakazono, M; Yamamoto, H | 1 |
| Barnes, JM; Barrett, A; Gornall, P; Huddart, SN; Mann, JR; Pearson, D; Raafat, F; Wallendsus, KR | 1 |
| Harvey, V; Levi, J; Raghavan, D; Thomson, D | 1 |
| Bosl, GJ; Geller, NL; Motzer, RJ | 1 |
| Bagshawe, KD; Ivory, C; Kelly, MP; Phillips, P; Rustin, GJ | 1 |
| Biddle, WC; Crickard, K; Crickard, U; Fanning, J; Foon, KA; Goldrosen, M; Piver, MS | 1 |
| Bosl, GJ; Fair, W; Geller, NL; Herr, H; Morse, M; Motzer, RJ; Russo, P; Sheinfeld, J; Sogani, P; Tan, CC | 1 |
| Bachy, B; Caillaud, JM; Flamant, F; Gruner, M; Hemet, J; Lefur, R; Lemerle, J; Tron, P; Vannier, JP | 1 |
| Buscema, J; Currie, JL; McLellan, R; Woodruff, JD | 1 |
| Akasaka, Y; Akaza, H; Deguchi, N; Fukui, I; Furuhata, A; Kawai, T; Komatsubara, S; Sakashita, S; Tobisu, K; Yamauchi, T | 1 |
| Blessing, JA; Hatch, KD; Homesley, HD; Williams, SD | 1 |
| Coulombier, DM; Spooner, SF | 1 |
| Bakri, YN; Nassar, M; Pedersen, P | 1 |
| Flanigan, P; Freshney, RI; Hamilton, TG; Kaye, SB; Merry, S | 1 |
| Leblanc, J; Sikorska, M; Smith, C; Walker, PR; Whitfield, JF; Youdale, T | 1 |
| Childers, JM; Surwit, EA | 1 |
| Kohorn, EI | 2 |
| Clancy, L; Daly, P; Kelly, P; O'Brien, AA | 1 |
| Andriessen, MP; Mulder, JG; Sleijfer, DT | 1 |
| Chrétien, P; Huot, J; Lambert, H; Landry, J; Roy, G | 1 |
| Bagshawe, KD; Begent, RH; Ledermann, JA; Newlands, ES; Philip, PA; Rustin, GJ | 1 |
| Arnold, ST; Felsted, RL; Politi, PM; Sinha, BK | 1 |
| Iqbal, Z; Mallick, JA; Zaidi, SH | 1 |
| Gilsanz, V; Isaacs, H; Laug, W; Ortega, JA; Ozkaynak, MF | 1 |
| Burns, I; Byrne, M; Gill, G; Harvey, V; Levi, JA; Raghavan, D; Sandeman, T; Snyder, R; Tattersall, M; Thomson, D | 1 |
| Jakobsson, M; Järvinen, M; Liippo, K; Nikkanen, V; Nordman, E; Ojala, A; Paloheimo, S | 1 |
| Fukuda, M; Matsuno, Y; Morita, M; Noguchi, M; Saijo, N; Sasaki, Y; Tsuchiya, R | 1 |
| Beattie, M; Kingston, JE; Malpas, JS; Norton, AJ | 1 |
| Arai, K; Mori, H; Ogino, M; Okinaga, S; Sakamoto, T; Yamamoto, T | 1 |
| de Góes, GM; Simon, SD; Srougi, M | 1 |
| Bielat, K; Castillo, NB; Lele, SB; Patsner, B; Piver, MS; Tsukada, Y | 1 |
| Bagshawe, KD; Begent, RH; Crawford, SM; Newlands, ES; Rustin, GJ | 2 |
| Bassoulet, J; Garetta, L; Raoul, Y | 1 |
| Bagshawe, KD; Begent, RH; Crawford, SM; Holden, L; Newlands, ES; Rustin, GJ | 2 |
| Auman, J; Bosl, GJ; Carey, R; Chan, E; Geller, NL; Herr, H; Morse, M; Sogani, P; Vogelzang, NJ; Whitmore, WF | 1 |
| Alexander, RB; Coffey, DS; Nelson, WG | 1 |
| Bagshawe, KD; Begent, RH; Newlands, ES; Pektasides, D; Rustin, GJ | 2 |
| Atlas, SA; Bosl, GJ; Leitner, SP; Preibisz, JJ; Scheiner, E; Sealey, JE | 1 |
| Bajorunas, D; Bosl, GJ | 1 |
| Bagshawe, KD; Begent, RH; Crawford, SM; Ledermann, JA; Newlands, ES; Rustin, GJ; Turkie, W | 1 |
| Bergmann, KA | 1 |
| Carter, GE; Daniels, JR; Lieskovsky, G; Skinner, DG | 1 |
| Bignon, YJ; Boiteux, JP; Chollet, P; Dauplat, J; Ferrière, JP; Giraud, B; Legros, M; Plagne, R | 1 |
| Dawson, NA; Knight, RD; McLeod, DG; Skoog, SJ; Taylor, HG; Waxman, JA | 1 |
| Aalders, JG; Bouma, J; Sleijfer, DT; Willemse, PH | 1 |
| Bosl, GJ; Fair, WR; Geller, NL; Golbey, R; Herr, H; Motzer, RJ; Penenberg, D; Sogani, P; Whitmore, WF; Yagoda, A | 1 |
| Tiuliandin, SA | 1 |
| Ban, Y; Ishihara, S; Iwata, H; Kanematsu, M; Komeda, H; Kuriyama, M; Oguchi, K; Takeuchi, T; Tanaka, T | 1 |
| Hida, S; Nishimura, K; Nishio, Y; Okada, K; Okada, Y; Yoshida, O | 1 |
| Dawson, NA; Knight, RD; McLeod, DG; Perry, DJ; Skoog, SJ; Taylor, G | 1 |
| Auman, J; Bajorin, D; Bosl, GJ; Carey, R; Geller, NL; Golbey, RB; Leitner, SP; Scher, H; Vogelzang, NJ; Yagoda, A | 1 |
| Clarke, J; Cullen, MH; Harper, PG; Kirkbride, P; Woodroffe, CM | 1 |
| Bagshawe, KD; Begent, RH; Hitchins, RN; Newlands, ES; Rustin, GJ; Smith, DB | 1 |
| Barnes, JM; Barrett, A; Mann, JR; Pearson, D; Raafat, F; Wallendszus, KR | 1 |
| Einhorn, LH; Loehrer, PJ; Seitz, DE; Williams, SD | 1 |
| Kotake, T; Kuroda, M; Miki, T | 1 |
| Athanassiou, A; Bafaloukos, D; Barbounis, V; Christodoulou, K; Dimitriadis, M; Pectasides, D | 1 |
| Bagshawe, KD; Begent, RH; Dent, J; Newlands, ES; Rustin, GJ | 1 |
| Hughes, CS; Shen, JW; Subjeck, JR | 1 |
| Donaldson, ES; Gallion, HH; Higgins, RV; van Nagell, JR | 1 |
| Davies, SL; Davies, SM; Harris, AL; Hickson, ID | 1 |
| Amiel, JL; Assouline, A; Azab, M; Bellet, D; Droz, JP; George, M; Michel, G; Piot, G; Theodore, C | 1 |
| Hamada, H; Ishida, Y; Minato, K; Ohtsu, T; Shimoyama, M; Sugimoto, Y; Tobinai, K; Tsuruo, T | 1 |
| Newlands, ES | 1 |
| Gisselbrecht, C; Le Doze, H; Le Duc, A; Mignot, L | 1 |
| Wilkinson, PM | 1 |
| Chang, A; Cheung, TH; Shiu, W; Wong, WS | 1 |
| Barondes, MJ; Hamilton, AM; Hungerford, J; Rustin, GJ | 1 |
| Kawashima, Y; Maeda, M; Sugimura, M | 1 |
| Surwit, EA | 1 |
| Calciati, A; Donadio, M; Ferrati, P; Giaccone, G; Testore, F | 1 |
| Brincker, H; Hansen, PV; Hindberg, J | 1 |
| Bolis, G; Bonazzi, C; Landoni, F; Mangili, G; Mangioni, C; Vergadoro, F; Zanaboni, F | 1 |
| Buckley, NJ; Das, AK; Poulton, SH; Walther, PJ | 1 |
| Bénard, J; Da Silva, J; Riou, G; Teyssier, JR | 1 |
| Holoye, PY | 1 |
| Bagshawe, KD; Begent, RH; Dent, J; Holden, L; Newlands, ES; Rustin, GJ | 1 |
| Calame, JJ; Dijkhuizen, GH; Franke, HR; Stolk, JG; Vermorken, JB; von Kessel, H | 1 |
| Díaz-Rubio García, E; González Larriba, JL; Martín Jiménez, M; Sangro Gómez-Acebo, B; Vila Borrajo, C | 1 |
| Kobayashi, O; Matsui, H; Sekiya, S; Takamizawa, H | 1 |
| Chen, TT; Coltman, CA; Crowley, JJ; Grozea, PN; Kies, MS; Livingston, RB; Mira, JG; Pazdur, R; Rivkin, SE; Ward, JH | 1 |
| Creagan, ET; Eagan, RT; Frytak, S; Lee, RE; Richardson, RL; Therneau, TM | 1 |
| Alexander, RB; Coffey, DS; Isaacs, JT | 1 |
| Sevitz, H | 1 |
| Fujii, T; Maeda, M | 1 |
| Beltangady, M; Crist, WM; Heyn, R; Johnston, J; Ragab, A; Raney, RB; Webber, B; Wharam, M | 1 |
| Kobayashi, O; Matsui, H; Takamizawa, H | 1 |
| Ito, H; Mitsuya, H; Miyake, K; Murase, T; Sobazima, T; Takashi, M | 1 |
| Bökkerink, JP; de Vries, JD; Debruyne, FM | 1 |
| Bagshawe, KD; Begent, RH; Newlands, ES; Parker, D; Rustin, GJ | 1 |
| Fiscella, R; Fishman, GA; Greenberg, D; Peyman, GA; Thomas, A | 1 |
| Alberts, DS; Christian, CD; Graham, VE; Surwit, EA | 1 |
| Stoter, G; van Groeningen, CJ | 1 |
| Chen, TT; Costanzi, JJ; Livingston, RB; McGavran, M; Mira, JG; Samson, M | 1 |
| Flamant, F; Gerbaulet, A; Lemerle, J; Leverger, G | 1 |
| Bakker, P; Laan, R; Lammes, FB | 1 |
| Bajorin, DF; Bosl, GJ; Mazumdar, M; Mencel, PJ; Motzer, RJ; Vlamis, V | 1 |
| Broun, ER; Einhorn, LH; Lazarus, HM; Loehrer, PJ; Nichols, CR; Roth, BJ; Turns, M; Williams, SD | 1 |
| Bosl, GJ; Motzer, RJ; Parker, RJ; Perera, F; Poirier, MC; Reed, E; Shamkhani, H; Tang, D; Tsai, WY | 1 |
| Bakri, Y; Berkowitz, RS; Goldstein, DP; Jabbar, FA; Senoussi, M; Subhi, J; von Sinner, W | 1 |
| Lurain, JR | 3 |
| Biran, H; Blickstein, I; Caspi, B; Dgani, R; Shoham, Z; Weissman, A; Zalel, Y | 1 |
| Bagshawe, KD; Begent, RH; Brampton, M; Holden, L; Ledermann, JA; Newlands, ES; Rustin, GJ | 1 |
| Bart, F; Cardot, E; Duquenne, O; Gosselin, B; Marquette, CH; Tonnel, AB | 1 |
| Carter, JR; Hartenbach, EM; Saltzman, AK; Twiggs, LB | 1 |
| Anteby, SO; Meirow, D; Reubinoff, BE; Tanos, V | 1 |
| Carpentier, AF; Chantelard, JV; Henin, D; Poisson, M | 1 |
| Bajorin, DF; Bosl, GJ; Motzer, RJ | 1 |
| Andrews, R; Begent, RH; Boshoff, C; Holden, L; Newlands, ES; Oliver, RT; Ong, J; Rustin, GJ; Skelton, M | 1 |
| Hayakawa, O; Kudo, R; Takehara, M | 1 |
| Pandha, HS; Wasan, HS; Waxman, J | 1 |
| Akaza, H; Hayashi, H; Koiso, K; Miyanaga, N | 1 |
| Aarbakke, J; Endresen, PC; Prytz, PS | 1 |
| Akaza, H; Miyanaga, N | 1 |
| Asano, K; Kawahara, M; Masuda, F; Shirakawa, H | 1 |
| Bower, M; Brock, C; Fisher, RA; Newlands, ES; Rustin, GJ | 1 |
| Bajorin, DF; Bosl, GJ; Motzer, RJ; Murphy, B; Rodriguez, E | 1 |
| Bajorin, DF; Bosl, GJ; Gulati, SC; Lyn, P; Mazumdar, M; Motzer, RJ; Vlamis, V | 1 |
| Hammond, CB; Olt, GJ | 1 |
| Berenson, J; Fady, C; Lichtenstein, A; Tu, Y; Vescio, R | 1 |
| Felix, CA; Hosler, MR; Lange, BJ; Masterson, M; Wilson, AE; Winick, NJ | 1 |
| Crist, W; Dickman, PS; Donaldson, SS; Fryer, C; Gehan, EA; Hammond, D; Hays, DM; Herrmann, J; Heyn, R; Ragab, AH | 1 |
| Archimbaud, E; Auzanneau, G; Cony-Makoul, P; Cordonnier, C; Dombret, H; Dreyfus, F; Fenaux, P; Leblond, V; Stoppa, AM; Troussard, X | 1 |
| Azuma, Y; Kizaki, H; Onishi, Y | 1 |
| Furukawa, S; Hayashi, K; Hayashi, Y; Kashiwagi, K; Kawashima, T; Nakajima, M; Ohta, J | 1 |
| Friedlander, M; Hammond, I; Jobling, T; Khoo, S; Marsden, D; Murray, J; Quinn, M; Steigrad, S | 1 |
| Kietlińska, Z; Sablińska, B; Zieliński, J | 1 |
| Bacci, G; Barbieri, E; Casadei, R; Fabbri, N; Ferrari, S; Ferraro, A; Mercuri, M; Picci, P; Rosito, P; Ruggieri, P | 1 |
| Eguchi, O; Inaba, N; Matsui, H; Takamizawa, H | 1 |
| Berchuck, A; Clarke-Pearson, DL; Evans, AC; Hammond, CB; Rodriguez, G; Soper, JT | 1 |
| de Campos, ES; Harris, M; Menasce, LP; Radford, J; Thatcher, N | 1 |
| de Veber, LL; Del Maestro, RF; Ramsay, DA; Sahjpaul, RL | 1 |
| Cohen, GM; Dinsdale, D; Ormerod, MG; Snowden, RT; Sun, XM | 1 |
| Hibi, S; Imashuku, S; Kataoka, Y; Morimoto, M; Naya, M; Takaya, K; Todo, S | 1 |
| Craft, AW; Davies, SM; Jones, PH; King, DJ; Kynaston, JA; Malcolm, AJ; Mitchell, CD; Oakhill, A; Stiller, CA | 1 |
| Amer, M; Bakri, YN; Ezzat, A; Jabbar, FA; Sinner, W; Subhi, J; Tweijry, A | 1 |
| Chitrathara, K; Gangadharan, VP; Nair, MK; Satishkumar, K; Sivaramakrishnan, R | 1 |
| Herrmann, C; Hiddemann, W; Meyer, T; Schauer, A | 1 |
| Bezwoda, WR; Lachter, J; Spencer, D; Stein, ME | 1 |
| Bertoglio, J; Bréard, J; Issaad, C; Léglise, MC; Pallardy, M; Roger, R; Turhan, AG | 1 |
| Jones, WB; Lewis, JL; Schneider, J; Shapiro, F | 1 |
| Dana, A; Doshi, R; Rustin, GJ; Saldanha, GJ | 1 |
| Cavanagh, D; Fiorica, JV; Gleeson, NC; Hoffman, MS; Roberts, WS | 1 |
| Cotter, TG; Samali, A | 1 |
| Bekradda, M; Culine, S; Droz, JP; Farhat, F; Terrier-Lacombe, MJ; Theodore, C | 1 |
| Frazier, AL; Green, DM; Grier, HE | 1 |
| Asaga, T; Kawahara, S; Osawa, Y; Yanoma, S; Yoshida, A | 1 |
| Bacci, G; Barbieri, E; Brach del Prever, A; Campanacci, M; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P | 1 |
| Bower, M; Fife, K; Holden, L; Newlands, ES; Paradinas, FJ; Rustin, GJ | 1 |
| Flam, F; Kock, E | 1 |
| Edwards, CL; Kavanagh, JJ; Kudelka, AP; Malpica, A; Varma, DG; Wright-Browne, V | 1 |
| Balat, O; Edwards, CL; Kavanagh, JJ; Kudelka, AP; Silva, E; Verschraegen, CF | 1 |
| Kemeny, AA; Leslie, MD; Mangili, G; Newlands, ES | 1 |
| Bagshawe, KD; Foskett, M; Fuller, S; Hiscox, JG; Holden, L; Lutz, JM; Newlands, ES; Rustin, GJ; Short, D | 1 |
| Hetzel, DJ; Mortel, R; Olt, GJ; Podczaski, ES; Singapuri, K; Sorosky, JI | 1 |
| Piette, J; Piret, B | 1 |
| Biemann, HP; Blenis, J; Davis, RJ; Juo, P; Konz, RF; Kuo, CJ; Raingeaud, J; Reynolds, SE | 1 |
| Kanazawa, K; Moromizato, H | 1 |
| Finegold, MJ; Gunawardena, SW; Ogden, AK; Trautwein, LM | 1 |
| Berkowitz, RS; Bernstein, MR; Goldstein, DP; Soto-Wright, V | 1 |
| Hirao, Y; Kaneko, Y; Momose, H; Okajima, E; Ozono, S; Samma, S; Tsumatani, K; Watanabe, S; Yamada, K | 1 |
| Court, BH; Culine, S; Droz, JP; Perrin, JL; Theodore, C | 1 |
| Aplan, PD; Chervinsky, DS; Stanulla, M; Wang, J | 1 |
| Broun, ER; Cornetta, K; Einhorn, LH; Gize, G; Hromas, RA; Nichols, CR; Schacht, B | 1 |
| Cohen, IJ; Horev, G; Kornreich, L; Michowiz, S; Shuper, A; Weitz, R; Zaizov, R | 1 |
| Bagshawe, KD; Begent, RH; Bower, M; Brock, C; Holden, L; Newlands, ES; Rustin, GJ; Short, D | 2 |
| Begent, RH; Bower, M; Holden, L; Newlands, ES; Rustin, GJ | 1 |
| Falaschi, A; Ochem, A; Phan, TN; Tuteja, N; Tuteja, R | 1 |
| Bacci, G; Barbieri, E; Brach Del Prever, A; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P; Ruggieri, P | 1 |
| Droz, JP | 1 |
| Bower, M; Brock, C; Holden, L; Makey, AR; Nelstrop, A; Newlands, ES; Rustin, GJ | 1 |
| Kimura, H; Momiki, S; Obata, S; Ogawa, T; Urabe, N; Yamaguchi, Y | 1 |
| Dragunow, M; MacGibbon, G; Saura, J | 1 |
| Fukuyama, K; Hayashi, S; Kojima, M; Matsubara, S; Nagata, M; Naitoh, K; Nakahara, Y; Tominaga, M | 1 |
| Ling, V; Shapiro, AB | 1 |
| Catton, C; Gospodarowicz, M; Jewett, M; Moore, M; Panzarella, T; Sturgeon, J; Warde, P | 1 |
| Bidziñski, M; Drabik, M; Lemieszczuk, B | 1 |
| Drescher, CW; Swisher, E | 1 |
| Bloom, SE; Muscarella, DE; Rachlinski, MK; Sotiriadis, J | 1 |
| Fink, FM; Heitger, A; Maurer, K; Niederweiser, D; Schwaighofer, H | 1 |
| Bacci, G; Barbieri, E; Brach del Prever, A; Ferrari, S; Forni, C; Mercuri, M; Picci, P; Rosito, P; Tienghi, A | 1 |
| Bagshawe, KD; Begent, RH; Bower, M; Holden, L; Newlands, ES; Rustin, GJ; Seckl, MJ; Short, D | 1 |
| Chan, HS; Doyle, J; Greenberg, ML; Karaskov, V; Koren, G; Malkin, D; Moncica, I; Theis, JG | 2 |
| Phan, TN; Tuteja, N | 1 |
| Blohm, ME; Bökkerink, JP; Calaminus, G; Dippert, S; Engert, J; Gadner, H; Göbel, U; Harms, D; Hass, RJ; Kaatsch, P; Teske, C; Waag, K | 1 |
| Anderson, E; Eden, O; Isaksson, O; Robson, H; Shalet, S | 1 |
| Anderson, E; Eden, OB; Isaksson, O; Robson, H; Shalet, S | 1 |
| Carabillò, M; Giuliano, M; Lauricella, M; Tesoriere, G; Vassallo, E; Vento, R | 1 |
| Iitsuka, Y; Matsui, H; Seki, K; Sekiya, S | 1 |
| Chambers, JT; Cracchiolo, B; Kohorn, EI; Odunsi, KO; Parkash, V; Peck, LL; Taylor, KJ | 1 |
| Chang, TC; Chou, HH; Hsueh, S; Huang, KG; Lai, CH; Tseng, CJ | 1 |
| Bae, SN; Han, KT; Jung, JK; Kim, CT; Kim, JH; Kim, SJ; Lee, JM | 1 |
| Bagshawe, KD; Bower, M; Foskett, M; Holden, L; Newlands, ES; Rustin, GJ; Short, D | 1 |
| Ahrens, S; Dunst, J; Hillmann, A; Hofmann, J; Jürgens, H; Paulussen, M; Rübe, C; Schuck, A; Willich, N | 1 |
| Golub, EI; Haaf, T; Raderschall, E | 1 |
| Coleman, RE; Gillespie, AM; Hancock, BW; Siddiqui, N | 1 |
| Coleman, RE; Dobson, LS; Gillespie, AM; Hancock, BW | 1 |
| Amarante-Mendes, GP; Cotter, TG; Finucane, DM; Green, DR; Martin, SJ; Salvesen, GS | 1 |
| Buendia, B; Courvalin, JC; Santa-Maria, A | 1 |
| Froelich, JJ; Schneller, FR; Zahn, RK | 1 |
| Akyol, D; Baltaci, V; Gökmen, O; Kozinoglu, H; Mungan, T; Oguz, S; Oztekin, O | 1 |
| Adami, GR; Buehler, PW; Negrusz, A; Robles, SJ | 1 |
| Amarante-Mendes, GP; Cotter, TG; Finucane, DM; Green, DR; Waterhouse, NJ | 1 |
| Gardner, RV; Shetty, AK; Warrier, RP; Yu, LC | 1 |
| Bekradda, M; Bensmaïne, MA; Brain, E; Cvitkovic, E; Di Palma, M; Garrino, C; Goupil, A; Misset, JL; Soulié, P | 1 |
| Bosl, GJ; Morris, MJ | 1 |
| Bacchini, P; Bacci, G; Bertoni, F; Donati, D; Ferrari, S; Forni, C; Longhi, A; Manfrini, M; Picci, P; Rimondini, S | 1 |
| Kinouchi, T; Kotake, T; Kuroda, M; Maeda, O; Meguro, N; Miki, T; Saiki, S; Usami, M | 1 |
| Holden, L; Mulholland, PJ; Newlands, ES; Rustin, GJ; Seckl, MJ | 1 |
| Cotter, TG; Knox, KA; McGahon, AJ; McKenna, SL; O'Gorman, DM | 1 |
| Dallaporta, B; Daugas, E; Kroemer, G; Loeffler, M; Maisse, C; Pablo, M; Zamzami, N | 1 |
| Gillespie, AM; Hancock, BW; Kumar, S | 1 |
| Coleman, RE; Dobson, LS; Hancock, BW; Lorigan, PC | 1 |
| Omura, GA | 1 |
| Anderson, JR; Baker, KS; Breneman, JC; Crist, WM; Grier, HE; Link, MP; Maurer, HM; Qualman, SJ; Wiener, ES | 1 |
| Kanazawa, K; Sakumoto, K; Suzuki, T | 1 |
| Iitsuka, Y; Matsui, H; Seki, K; Sekiya, S; Suzuka, K | 1 |
| Anthoney, A; de Bono, JS; Graham, J; Kaye, SB; Kirk, D; Paul, J; Simpson, A; Underwood, M | 1 |
| Matsuzaki, J; Miura, T; Miyoshi, Y | 1 |
| Brandao, L; Cain, AM; Kun, LE; McCarville, MB; Pappo, AS; Poquette, CA; Spunt, SL | 1 |
| Falcovitz, A; Goldfinger, N; Gorbunova, V; Milyavsky, M; Rotter, V; Seluanov, A; Shohat, G; Sigal, A; Zurer, I | 1 |
| Iitsuka, Y; Matsui, H; Seki, K; Sekiya, S; Suzuka, K; Yamazawa, K | 1 |
| Cantoni, C; Daga, A; Lunardi, C; Millo, R; Oliveri, M; Puccetti, A | 1 |
| Weiss, M | 1 |
| Han, S; Xiang, Y; Yang, X | 1 |
| De Marzi, P; Garavaglia, E; Mangili, G; Taccagni, G; Zanetto, F | 1 |
| Clayman, GL; Guan, B; Sun, SY; Yue, P | 1 |
| Cory, AH; Cory, JG | 1 |
| Ben-Arie, A; Biran, H; Dgani, R; Hagay, Z; Open, M; Piura, B | 1 |
| Altintaş, A; Vardar, MA | 1 |
| Blair, IA; Felix, CA; Lo Nigro, L; Lovett, BD; Megonigal, MD; Nowell, PC; Osheroff, N; Rappaport, EF; Williams, WR; Zheng, N | 1 |
| Crooke, MJ; Delahunt, B; Lewis, ME; Pringle, KC; Wiltshire, EJ | 1 |
| Gillmore, R; Kendall, A; Newlands, E | 1 |
| Arcaro, A; Downward, J; Pardo, OE; Raguz, S; Salerno, G; Seckl, MJ | 1 |
| Ahrens, S; Aulitzky, WE; Dunst, J; Fölsch, UR; Göbel, U; Harms, D; Hense, HW; Henze, G; Jürgens, H; Kremens, B; Lehnert, M; Niemeyer, C; Paulussen, M; Reiter, A; Taeger, D; Voûte, PA; Wagner, A; Zoubek, A | 1 |
| Anderson, JR; Barr, FG; Crist, WM; Donaldson, SS; Maurer, HM; Pappo, AS; Qualman, SJ; Raney, RB; Wiener, ES | 1 |
| Breitfeld, PP; Crist, WM; Donaldson, SS; Lobe, T; Lyden, E; Maurer, HM; Raney, RB; Ruymann, FB; Teot, LA; Wharam, M | 1 |
| Foskett, M; Holden, L; McNeish, IA; Newlands, ES; Rustin, GJ; Seckl, MJ; Strickland, S | 1 |
| Brooks, SE; Goldstein, DP; Ioffe, O; Knox, S; Meisenberg, B; Wong-You-Cheong, J | 1 |
| Ahrens, S; Dunst, J; Jürgens, H; Könemann, S; Paulussen, M; Rübe, C; Rübe, CE; Schuck, A; Willich, N | 1 |
| Amato, RJ; Daliani, D; Do, KA; Finn, L; Fizazi, K; Kim, J; Logothetis, CJ; Millikan, RE; Pagliaro, LC; Papandreou, CN; Prow, DM; Tu, SM; Wang, X | 1 |
| Holden, L; McNeish, I; Newlands, ES; Rustin, GJ; Seckl, MJ; Strickland, S | 1 |
| Corcos, L; Logette, E; Solary, E; Solier, S; Wotawa, A | 1 |
| Kamura, T; Ohta, S; Sugiyama, T; Tomonari, R | 1 |
| Shimizu, T; Yaegashi, N | 1 |
| Alici, S; Argon, A; Aydiner, A; Basaran, M; Eralp, Y; Saip, P; Topuz, E | 1 |
| Biron, P; Bompas, E; Droz, JP; Fléchon, A | 1 |
| Kawasaki, T; Nakayama, M; Oka, K; Okane, M; Shiina, H; Tanno, W | 1 |
| Buglova, SE; Ismail-zade, RS; Potapnev, MP; Rud'ko, VS; Sachivko, NV; Semenov, AS; Shman, TV; Zhavrid, EA | 1 |
| Hori, M; Koyama, K; Ogasawara, T; Tsubamoto, H; Tsuji, Y | 1 |
| Blütters-Sawatzki, R; Gossen, R; Neugebauer, M; Reiter, A; Woessmann, W | 1 |
| Bartos, J; Kylarová, D; Lichnovský, V; Mad'arová, J; Procházková, J | 1 |
| Hosoi, H; Iehara, T; Misawa, A; Sawada, T; Sugimoto, T; Tsuchiya, K | 1 |
| Iitsuka, Y; Matsui, H; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N; Yamazawa, K | 1 |
| Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ | 2 |
| Chen, C; Goldwein, JW; Maity, A; Shu, HK; Womer, RB | 1 |
| Depatie, C; Hayakawa, J; Mercola, D; Ohmichi, M | 1 |
| Baertschi, E; Bargetzi, MJ; Mironov, A; Notter, M; Wernli, M | 1 |
| Dalrymple, C; Lee, V; Parker, A; Russell, P; Valmadre, S | 1 |
| Laberge, JM | 1 |
| Ansink, AC; Lok, CA; ten Kate-Booij, MJ; van der Houwen, C; van Eijkeren, MA | 1 |
| Ren, T; Wan, XR; Xiang, Y; Yang, XY; Zhang, ZY | 1 |
| Hoffarth, S; Huber, C; Milosevic, J; Schuler, M | 1 |
| Begent, RH; Fuller, S; Gaffan, J; Holden, L; Newlands, ES; Rustin, GJ; Seckl, MJ; Short, D | 1 |
| Rikiishi, H; Sato, K; Shinohara, F; Suzuki, M; Takada, H; Taniguchi, T | 1 |
| Bilgin, T; Ozan, H; Ozkan, L; Ozuysal, S | 1 |
| Bozorgi, K; Escobar, PF; Fishman, DA; Lurain, JR; Singh, DK | 1 |
| Ansink, AC; Lammes, FB; Lok, CA; Rietbroek, RC; Ten Kate-Booij, MJ; van der Houwen, C | 1 |
| Amodeo, R; Anghel, G; De Rosa, L; Majolino, I; Pandolfi, A; Riccardi, M | 1 |
| Bielawski, J; Dbaibo, GS; Gillanders, WE; Hannun, YA; Johnson, KR; Kozhaya, L; Obeid, LM; Osta, W; Taha, TA | 1 |
| Campiani, G; Greene, LM; Lawler, M; Ledwidge, S; Mc Gee, MM; Nacci, V; Williams, DC; Zisterer, DM | 1 |
| Garriott, ML; Hoffman, WP; Lee, C; Murphy, GP; Phelps, JB | 1 |
| Behtash, N; Ghaemmaghami, F; Hanjani, P; Soleimani, K | 1 |
| Iitsuka, Y; Matsui, H; Mitsuhashi, A; Sekiya, S; Suzuka, K; Yamazawa, K | 1 |
| Sun, Z; Wan, X; Xiang, Y; Yang, X | 1 |
| Bonazzi, C; Buda, A; Cantú, MG; Dell'Anna, T; Sacco, S; Urso, M | 1 |
| Billups, CA; Davidoff, AM; Krasin, MJ; Kun, LE; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
| Akansel, G; Arisoy, AE; Calişkan, M; Corapcioglu, F; Dillioğlugil, O; Sarper, N | 1 |
| Sugiura, H; Suzuki, Y; Takahashi, M; Yamada, K | 1 |
| Eren, E; Metindir, J; Ozdilekcan, C; Pak, I | 1 |
| Matsui, H; Mitsuhashi, A; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N; Yamazawa, K | 1 |
| Bouvet, N; Ellershaw, C; Flamant, F; Habrand, JL; Marsden, HB; Martelli, H; Oberlin, O; Rey, A; Sanchez de Toledo, J; Spicer, RD; Spooner, D; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
| Debatin, KM; Fulda, S | 1 |
| Sun, ZJ; Wan, XR; Xiang, Y; Yang, XY | 1 |
| Ren, T; Wan, XR; Xiang, Y; Yang, XY; Zhang, Y | 1 |
| Lurain, JR; Nejad, B | 1 |
| Billups, CA; Davidoff, AM; Fuller, CE; Krasin, MJ; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
| Burger, CW; Ewing, P; Seynaeve, C; Snijders-Keilholz, A | 1 |
| Abelairas Gómez, JM; Calvo, JM; Olivier Pascual, N | 1 |
| Oberlin, O; Orbach, D; Quintana, E; Rey, A; Sanchez de Toledo, J; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
| Hiramatsu, Y; Ishida, M; Masuyama, H; Murakami, K; Sakurai, M | 1 |
| Brockmann, WG; Eick, JD; Kostoryz, EL | 1 |
| Ajufo, II; Canty, SH; Lindow, SW | 1 |
| Amikura, T; Aoki, Y; Banzai, C; Nishikawa, N; Sekine, M; Suzuki, M; Tanaka, K; Yokoo, T | 1 |
| Bisogno, G; Casale, F; Cecchetto, G; De Salvo, G; Di Martino, M; Di Tullio, MT; Donfrancesco, A; Donofrio, V; Ferrari, A; Indolfi, P; Martone, A | 1 |
| Chen, L; Dong, RF; Liu, N; Wan, XR; Wu, Y; Xiang, Y; Yang, XY | 1 |
| Constantinidis, J; Dimmler, A; Iro, H; Koch, M; Strauss, C | 1 |
| Beckwith, JB; Breslow, NE; Coccia, P; Coppes, MJ; Cotton, CA; Dome, JS; Donaldson, M; Green, DM; Grundy, PE; Haase, GM; Kalapurakal, JA; Kletzel, M; Macklis, RM; Malogolowkin, M; Perlman, EJ; Ritchey, ML; Shamberger, RC; Weetman, RM | 1 |
| Goyal, HK; Katiyar, D; Mukherjee, U; Pendharkar, D; Thakur, V | 1 |
| Mai, WY; Nguyen, TX; Paulino, AC; Teh, BS; Wen, BC | 1 |
| Wan, X; Xiang, Y; Yang, J; Yang, X | 1 |
| Ansink, AC; Grootfaam, D; Lok, CA; ten Kate-Booij, MJ; van der Velden, J; Verheijen, RH | 1 |
| Katski, K; Kołłataj, B; Kołłataj, W; Majewski, M; Pijanowska, M; Sikora, P; Zajaczkowska, M | 1 |
| Bernstein, M; Chen, Z; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, M; Laurie, F; Miser, JS; Tarbell, NJ; Yock, TI | 1 |
| Anderson, J; Meyer, WH; Meza, JL; Pappo, AS | 1 |
| Bai, J; Cederbaum, AI | 1 |
| Askin, FB; Bhatia, S; Burden, L; Chen, Z; Dickman, PS; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Perlman, EJ; Rausen, AR; Robison, LL; Vietti, TJ | 1 |
| Akaza, H; Hasegawa, Y; Hattori, K; Hinotsu, S; Kawai, K; Kojima, H; Miyanaga, N; Oikawa, T; Sekido, N; Shimazui, T | 1 |
| Lurain, JR; Schink, JC; Singh, DK | 2 |
| Cagayan, MS; Lu-Lasala, LR | 1 |
| Clarke-Pearson, DL; Kirkpatrick, JP; Sampson, JH; Soper, JT; Spillman, M; Wolf, JK | 1 |
| Boven, E; Meijer, OW; Smorenburg, CH; van Groeningen, CJ; Visser, M | 1 |
| Breslow, NE; Feusner, JH; Green, DM; Norkool, PA; Ritchey, ML; Takashima, JR | 1 |
| Lv, W; Mao, Y; Wan, X; Xie, X | 1 |
| Beckwith, JB; Breslow, NE; Coccia, P; Coppes, MJ; Cotton, CA; D'Angio, GJ; Donaldson, M; Green, DM; Grundy, PE; Haase, GM; Huff, V; Kletzel, M; Macklis, R; Malogolowkin, M; Miser, J; Newbury, R; Perlman, E; Ritchey, ML; Shamberger, RC; Shearer, P; Thomas, PR; Tomlinson, G; Weeks, D; Weetman, R | 1 |
| Ansell, W; Asterling, S; Berney, D; Joel, SP; Liu, S; Mutsvangwa, K; Oliver, RT; Powles, T; Shamash, J; Stebbing, J; Wilson, P; Wyatt, P | 1 |
| El-Helw, LM; Hancock, BW | 1 |
| Bae, SN; Jung, SG; Kim, CJ; Kim, SJ; Lee, C; Na, YJ | 1 |
| Chen, L; Dong, R; Liu, N; Wan, X; Wu, Y; Xiang, Y; Yang, X | 1 |
| Barbetti, A; Buccoliero, AM; Castiglione, F; Garbini, F; Gheri, CF; Moncini, D; Rossi Degl'Innocenti, D; Taddei, GL; Villanucci, A | 1 |
| Chang, WT; Chen, CL; Huang, WC; Lin, CF; Lin, YS; Teng, CF | 1 |
| Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J | 1 |
| Ashrafgangooei, T; Azamolsadat, M; Behroozi, S; Behtash, N; Fatemeh, G; Ghaemmaghami, F; Ghanbari, Z; Gilani, MM; Mitra, MG; Mousavi, A; Nadereh, B; Shohreh, B; Tahereh, A; Zinat, G | 1 |
| Affolter, A; Ahmed, M; Marais, R; Nutting, CM; Pritchard-Jones, K; Sharma, AK; Thomas, V; Venkitaraman, R | 1 |
| Hsieh, TY; Hsu, KF; Huang, SC; Kuo, PL | 1 |
| Ayas, S; Cetiner, H; Gurbuz, A; Karateke, A | 1 |
| Green, DM | 1 |
| Berkowitz, RS; Fülöp, V; Szepesi, J; Szigetvŕi, I; Török, M | 1 |
| Behnamfar, F; Behtash, N; Hamedi, B; Ramezanzadeh, F | 1 |
| Behnamfar, F; Mousavi, SA | 1 |
| Cassoni, A; Craft, AW; Douglas, C; Dunst, J; Grimer, R; Hackshaw, A; Hunold, A; Jürgens, H; Köhler, G; Ladenstein, R; Lewis, I; McTiernan, A; Paulussen, M; Poremba, C; Schuck, A; Spooner, D; van den Berg, H; Whelan, J; Winkelmann, W; Zoubek, A | 1 |
| Bischoff, J; Costa, SD; Ignatov, A; Smith, B; Taran, A | 1 |
| Daw, NC; Gregornik, D; Jenkins, JJ; Jones, DP; Kun, LE; Marina, N; McPherson, V; Rodman, J; Wilimas, J; Wu, J | 1 |
| Kim, KJ; Kim, YD; Lee, YH | 1 |
| Cao, Y; Feng, FZ; Li, L; Wan, XR; Xiang, Y; Yang, XY | 1 |
| Belfort, P; Braga, A; Consonni, M; Delmanto, LR; Maestá, I; Michelin, OC; Rudge, MV | 1 |
| Anderson, ML; Beasley, AD; Coleman, NM; Kolomeyevskaya, NV; Miller, HJ; Tanyi, JL | 1 |
| Bielack, SS; Brecht, I; Dantonello, TM; Dickerhoff, R; Gadner, H; Greiner, J; Greulich, M; Harms, D; Herbst, M; Int-Veen, C; Juergens, H; Kirsch, S; Klingebiel, T; Koscielniak, E; Leuschner, I; Marky, I; Scheel-Walter, HG; Schmelzle, R; Schmidt, BF; Treuner, J | 1 |
| Arndt, CA; Bernstein, M; Devidas, M; Dickman, P; Gebhardt, M; Goorin, A; Granowetter, L; Grier, HE; Healey, J; Krailo, M; Leavey, P; Marcus, K; Marina, N; Meyer, J; Miser, J; Perlman, E; Sailer, S; Shamberger, RC; Wang, C; Womer, R | 1 |
| DuBois, SG; Grier, HE | 1 |
| Al-Hussaini, M; Ali, HM; Almousa, A; Ghandour, K; Ismael, T; Masarweh, M; Rodriguez-Galindo, C; Sultan, I | 1 |
| Cao, Y; Feng, F; Wan, X; Xiang, Y; Yang, X | 1 |
| Bacci, G; Balladelli, A; Briccoli, A; Di Fiore, M; Ferrari, C; Palmerini, E; Rocca, M; Salone, M | 1 |
| Agarwal, R; Fisher, RA; Hancock, B; Lindsay, I; Nagai, Y; Newlands, ES; Savage, PM; Schmid, P; Sebire, NJ; Seckl, MJ; Short, D; Wells, M; Wischnewsky, MB | 1 |
| Athale, UH; Barr, R; Duckworth, J; Odame, I | 1 |
| Pappo, A; Paulino, AC | 1 |
| Bottone, MG; Pellicciari, C; Scovassi, AI; Soldani, C; Veneroni, P | 1 |
| Alpini, C; Bottone, MG; Pellicciari, C; Perdoni, F; Scovassi, AI; Soldani, C; Veneroni, P | 1 |
| Bleyer, A; Choi, M; Fuller, CD; Raney, RB; Wang, SJ | 1 |
| Konno, R; Netsu, S; Nokubi, M; Ohmaru, T; Yamakawa, H | 1 |
| Cao, Y; Feng, F; Xiang, Y | 1 |
| He, DW; Li, XL; Lin, T; Liu, JH; Liu, X; Wei, GH; Zhang, DY | 1 |
| Anderson, JR; Huh, WW; Raney, RB; Rodeberg, D; Teot, L; Yock, T | 1 |
| Aydin, A; Balat, O; Cebesoy, FB; Ozturk, E; Sever, T; Ugur, MG | 1 |
| Bohlson, SS; Greenlee-Wacker, MC; Kozmar, A | 1 |
| Cho, YL; Choi, MH; Hong, DG; Lee, YS; Park, IS | 1 |
| Huh, YJ; Park, JW; Yang, ES | 1 |
| Craft, A; Dirksen, U; Hjorth, L; Jürgens, H; Ladenstein, R; Le Deley, MC; Lewis, I; Michon, J; Oberlin, O; Paulussen, M; Pötschger, U; van den Berg, H; Whelan, J | 1 |
| El-Baz, M; Ghali, AM; Ghoneim, MA; Sarhan, MM; Sarhan, OM | 1 |
| Fujisawa, M; Miyake, H; Muramaki, M; Takenaka, A; Terakawa, T | 1 |
| Alberghini, M; Alvegard, TA; Bacci, G; Barbieri, E; Brach Del Prever, A; Capanna, R; Carli, M; Fagioli, F; Ferrari, S; Gandola, L; Luksch, R; Mapelli, S; Mercuri, M; Picci, P; Prete, A; Smeland, S; Sundby Hall, K; Tamburini, A; Tienghi, A; Wiebe, T | 1 |
| Kumabe, T; Niizuma, H; Osawa, S; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M | 1 |
| Feng, F; Geng, S; Wan, X; Wang, T; Xiang, Y | 1 |
| Aoki, Y; Asato, K; Hirakawa, M; Inamine, M; Kudaka, W; Nagai, Y; Suzuki, S; Wakayama, A | 1 |
| Harvey, R; Mitchell, H; Savage, P; Schmid, P; Seckl, M; White, S | 1 |
| Khunamornpong, S; Settakorn, J; Siriaunkgul, S; Sukpan, K; Suprasert, P | 1 |
| Kopacek, J; Krizanova, O; Labudova, M; Lencesova, L; Ondrias, K; Pastorekova, S; Sirova, M | 1 |
| Pham, XH; Tran, NQ; Tuteja, N; Tuteja, R | 1 |
| Gilbert, B; Janssen-Megens, E; Koeppel, M; Lohrum, M; Smeenk, L; Stunnenberg, HG; van Heeringen, SJ | 1 |
| Cho, J; Cho, WH; Jeon, DG; Kim, DH; Kim, MS; Koh, JS; Kong, CB; Lee, JA; Lee, SY; Lim, JS; Song, WS; Yoo, JY | 1 |
| Delaplace, M; Goré, C; Machet, L; Mélard, P; Perrinaud, A; Vergier, B | 1 |
| Bircher, C; Brown, D; McCarthy, A; Nirmal, DM; Rees, H; Seckl, MJ; Short, D; Smith, RP | 1 |
| Cyriac, S; Rajendranath, R; Sagar, TG; Sridevi, V | 1 |
| Hamano, K; Harada, M; Inoue, T | 1 |
| Agarwala, S; Bisoi, AK; Das, S; Gupta, AK; Malankar, DP; Munghate, G; Sugandhi, N | 1 |
| Raveesunthornkiet, M; Ruangtrakool, R; Sanpaki, K; Thorner, PS; Treetipsatit, J | 1 |
| Cao, D; Chen, J; Guo, L; Lang, J; Shen, K; Tao, T; Yang, J | 1 |
| Cole, LA | 1 |
| Burchill, SA; Roundhill, EA | 1 |
| Aydiner, A; Bengisu, E; Berkman, S; Ilhan, HR; Keskin, S; Tas, F; Topuz, E | 1 |
| Colpan Oksuz, D; Dervisoglu, S; Hiz, M; Kantarci, F; Koca, S; Molinas Mandel, N; Oner Dincbas, F; Selcukbiricik, F; Tural, D; Turna, H | 1 |
| Cohen, S; Condous, G; Harnett, P; Pixton, S; Reid, S | 1 |
| Lacy-Hulbert, A; Païdassi, H; Paquette, N; Perez, B; Skvirsky, R; Stuart, LM; White, K; Zhai, B | 1 |
| Alpini, C; Bottone, MG; Santin, G; Scovassi, AI; Soldani, C; Veneroni, P | 1 |
| Breitenbuecher, F; Guyot, M; Hoffarth, S; Höhn, Y; Meiler, J; Schuler, M; Wesarg, E | 1 |
| Amant, F; Devi, UK; Han, SN; Leunen, K; Neven, P; Vergote, I | 1 |
| Bergeron, C; Bouvet, N; Ellershaw, C; Jenney, ME; Kelsey, A; Martelli, H; Merks, JH; Oberlin, O; Rey, A; Sanchez de Toledo, J; Scopinaro, M; Spooner, D; Stevens, MC | 1 |
| Lybol, C; Massuger, LFAG; Ottevanger, PB; Sweep, FCGJ; Thomas, CMG; Westerdijk, K | 1 |
| Baptista, AM; Belfort, P | 1 |
| Centen, DW; Lybol, C; Massuger, LF; Ottevanger, PB; Sweep, FC; ten Kate-Booij, MJ; Thomas, CM; Verheijen, RH | 1 |
| Ash, S; Cohen, IJ; Feinmesser, M; Kornreich, L; Kuperman, AA; Yaniv, I | 1 |
| Andersen, CY; Birkebæk, NH; Clausen, N; Ernst, E; Kjærsgaard, M | 1 |
| Blanken, EA; Boere, IA; Lybol, C; Massuger, LF; Ottevanger, PB; Reyners, AK; Sweep, FC; Thomas, CM; van Hoesel, RQ; Verheijen, RH; Westermann, AM | 1 |
| Akagi, J; Darzynkiewicz, Z; Dobrucki, J; Errington, R; Kordon, M; Matuszek, A; Smith, PJ; Takeda, K; Wlodkowic, D; Zhao, H | 1 |
| Agarwal, R; Alifrangis, C; Fisher, RA; Harvey, R; Savage, PM; Sebire, NJ; Seckl, MJ; Short, D | 1 |
| Goto, M; Hirokawa, W; Iwase, A; Kikkawa, F; Kondo, M; Nakahara, T; Nakamura, T; Sugita, A; Takikawa, S; Yamamoto, E | 1 |
| Choi, YJ; Chun, KY; Kim, YW; Ro, DY | 1 |
| Ahn, DG; Gujar, S; Lee, PW; Marcato, P; Pan, D; Pan, LZ; Shmulevitz, M | 1 |
| Aggarwal, N; Agrawal, M; Chopra, S; Rana, SS; Raveendran, A; Sikka, P; Suri, V | 1 |
| Benigno, BB | 1 |
| Bajpai, J; Deodhar, K; Gulia, S; Gupta, S; Kerkar, RA; Maheshwari, A; Menon, S; Rekhi, B; Seth, V | 1 |
| Hayashi, T; Ishii, T; Itami, Y; Kobayashi, Y; Minami, T; Nagai, Y; Nozawa, M; Shimizu, N; Uemura, H; Yamamoto, Y; Yoshimura, K | 1 |
| Cormenzana, M; García-Esparza, E; Hernández-Marqués, C; Lassaletta, A; Madero-López, L | 1 |
| Bi, K; Chen, F; Fan, J; Hou, M; Liu, G; Ran, X; Wang, J; Wang, L; Wang, M; Wang, X; Wang, Z; Xu, R; Yang, E; Yang, S; Yu, W; Zhao, H | 1 |
| Maherus, EM; Rashidi, A | 1 |
| Augereau, P; Balleyguier, C; Droz, JP; Duvillard, P; Even, C; Fizazi, K; Floquet, A; Kerbrat, P; Leary, A; Lhommé, C; Morice, P; Pautier, P; Rey, A; Tazi, Y; Troalen, F | 1 |
| Brennan, B; Craft, A; Dirksen, U; Hjorth, L; Judson, I; Juergens, H; Ladenstein, R; Le Deley, MC; Le Teuff, G; Lewis, I; Marec-Bérard, P; Michon, J; Oberlin, O; Paulussen, M; Ranft, A; van den Berg, H; Wheatley, K; Whelan, J | 1 |
| Feng, FZ; Ren, T; Wan, XR; Wang, T; Xiang, Y | 1 |
| Biasoni, D; Catanzaro, M; Farè, E; Giannatempo, P; Gianni, AM; Marongiu, M; Miceli, R; Necchi, A; Nicolai, N; Piva, L; Raggi, D; Salvioni, R; Stagni, S; Torelli, T | 1 |
| Frenel, JS; Nowak, C; Philippe, HJ; Sagan, C; Tardif, C | 1 |
| Ashton, E; Hoffman, J; Shafer, A; Szutowska, M | 1 |
| Ahmad, S; Ahmed, M; Al-Badawi, IA; Al-Hashem, H; Al-Hayli, S; Al-Husaini, H; Darwish, A; Edesa, W; Elghamry, W; Elhassan, T; Eltigani, A; Madkhali, I; Omar, A; Soudy, H | 1 |
| Beck, JF; Ebinger, M; Feuchtinger, T; Furtwängler, R; Greil, J; Handgretinger, R; Illhardt, T; Klingebiel, T; Lang, P; Schlegel, PG; Schwarze, CP | 1 |
| Gilani, MM; Khorasanizadeh, F; Mousavi, AS; Zamani, A; Zendehdel, K | 1 |
| Camarata, M; Cooke, R; Dancy, G; Krell, J; Kwan, A; O'Nions, J; Savage, P; Seckl, MJ; Short, D; Swerdlow, A | 1 |
| Agarwala, S; Bakhshi, S; Biswas, B; Deo, SV; Khan, SA; Mohanti, BK; Rastogi, S; Sharma, MC; Shukla, NK; Vishnubhatla, S | 1 |
| Kelpanides, I; Savage, P; Seckl, MJ; Short, D; Tuthill, M | 1 |
| Berkowitz, RS; Bernstein, MR; Goldstein, DP; Horowitz, NS; Maestá, I; Moulder, J; Ramírez, LA | 1 |
| Feng, F; Ren, T; Wan, X; Xiang, Y; Xiao, C; Yang, J; Zhao, J | 1 |
| Berkowitz, RS; Bernstein, MR; Goldstein, DP; Horowitz, NS; Maestá, I; Ramírez, LA | 1 |
| Ahmad, K; Chiba, T; Gilbert, B; Groner, B; Lehmann, C; Maier, TJ; Roos, J; Smeenk, L; Steinhilber, D; Ulrich-Rückert, S; van Heeringen, S | 1 |
| Faaborg, L; Hansen, ES; Lindegaard, JC; Niemann, I; Ostenfeld, EB; Sunde, L | 1 |
| Boonyapipat, S; Rattanaburi, A; Supasinth, Y | 1 |
| Abdi, S; Coleman, RE; Hancock, BW; Lo, C; Price, JM; Tidy, J; Winter, MC | 1 |
| Altman, AD; Alwazzan, AB; Dean, E; Lotocki, R; Popowich, S; Robinson, C | 1 |
| Engert, F; Fulda, S; Probst, M; Schneider, C; Weiβ, LM | 1 |
| Mo, J; Murphy, EP; Yoon, JM | 1 |
| Bae, SN; Byun, SW; Park, TC | 1 |
| Fukuda, T; Hashiguchi, Y; Ichimura, T; Kasai, M; Kuno, I; Matsumoto, Y; Sumi, T; Yasui, T | 1 |
| Nevado-Gammad, MS; Soriano-Estrella, AL | 1 |
| Mu, Q; Wan, Y; Xiao, S; Xue, M | 1 |
| Cosio, S; Fanucchi, A; Gadducci, A; Manacorda, S; Pistolesi, S; Strigini, FL; Tana, R | 1 |
| Feng, F; Ren, T; Wan, X; Xiang, Y; Yang, J | 1 |
| Berkowitz, RS; Braga, A; Burlá, M; Elias, KM; Lin, L; Madi, JM; Maestá, I; Sun, SY; Torres, B; Uberti, E; Viggiano, M | 1 |
| Msaouel, P; Tu, SM; Zhang, M | 1 |
| Chao, TK; Hou, WC; Kao, CC; Lai, YJ; Li, HM; Su, HY; Yu, MH | 1 |
| Eysbouts, YK; IntHout, J; Lok, CAR; Massuger, LFAG; Ottevanger, PB; Sweep, FCGJ | 1 |
| Feng, F; Jiang, F; Kong, Y; Li, J; Ren, T; Wan, X; Wang, X; Xiang, Y; Yang, J; Zhao, J | 1 |
| Brown, J; Bruegl, A; Essel, KG; Gershenson, DM; Naumann, RW; Ramondetta, LM | 1 |
| Guo, N; Li, Q; Song, L; Wang, D; Yin, R | 1 |
| Peng, L; Yang, M | 1 |
| Bergamini, A; Candiani, M; Cioffi, R; Cormio, G; Gadducci, A; Giorgione, V; Mangili, G; Pella, F; Petrone, M; Rabaiotti, E | 1 |
| Boddy, AV; Chatelut, E; Osborne, C; Paci, A; Veal, GJ; White-Koning, M | 1 |
| Anderson, JR; Chi, YY; Dix, DB; Dome, JS; Ehrlich, PF; Fernandez, CV; Gastier-Foster, JM; Geller, JI; Gratias, E; Grundy, PE; Kalapurakal, JA; Khanna, G; Malogolowkin, M; Mullen, EA; Paulino, AC; Perlman, EJ; Seibel, NL; Wagner, E | 1 |
| Li, G; Tong, T; Xu, C; Yuan, F | 1 |
| Fu, C; Huang, R; Liang, Y; Ren, Z; Xie, M; Yu, L; Zhang, Z; Zhu, F | 1 |
| Harada, N; Haruta, N; Higashiura, Y; Hisanaga, H; Nobuhara, I; Sado, T; Watanabe, H; Watanabe, S | 1 |
| Coulter, J; Frijstein, MM; Golfier, F; Lok, CAR; Massuger, LFAG; Seckl, MJ; Ten Kate-Booij, MJ; van Trommel, NE | 1 |
| Caval, V; Durandy, A; Mussil, B; Suspène, R; Vartanian, JP; Wain-Hobson, S | 1 |
| Berkowitz, RS; Braga, A; Dos Santos Esteves, APV; Elias, KM; Filho, JR; Horowitz, NS; Mora, PAR; Sun, SY; Uberti, EH; Velarde, GC | 1 |
| Berbegall, AP; Blanquer-Maceíras, MT; Ferrández, A; Machado, I; Martinez-Ciarpaglini, C; Navarro, S; Nieto, G; Noguera, R; Yoshida, A | 1 |
| Burchill, SA; Jabri, S; Roundhill, EA | 1 |
| Barroilhet, L; Buza, N; Hui, P; McGregor, SM; Zheng, X | 1 |
| Jiang, B; Wu, Q; Yan, LJ | 1 |
| Anderson, J; Beavis, AL; Chau, DB; Gocke, CD; Jenson, E; Nickles Fader, A; Ronnett, BM; Stone, R | 1 |
| Bergamaschi, L; Bertulli, R; Casanova, M; Chiaravalli, S; Collini, P; Diletto, B; Ferrari, A; Fiore, M; Gandola, L; Gasparini, P; Massimino, M; Morosi, C; Provenzano, S; Sangalli, C | 1 |
| Ino, K; Kajiyama, H; Kikkawa, F; Kotani, T; Niimi, K; Nishino, K; Sato, S; Suzuki, S; Yamamoto, E | 1 |
| Khalifeh, I; Maroun, CA; Moukarbel, RV; Tfayli, A | 1 |
| Anderton, J; Brennan, B; Evans, A; Fenwick, N; Fernández-Pinto, M; Gaspar, N; Gelderblom, H; Kaiser, S; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
| Aftandilians, T; Dombrovsky, I; Stowe, RJ; Tilden, HR; Wong, S | 1 |
| Bisogno, G; Hawkins, DS | 1 |
| Berkowitz, RS; Elias, KM; Goldstein, DP; Horowitz, NS; Jareemit, N | 1 |
| Al-Rohil, RN; Bentley, RC; Cardona, DM; Feng, X; Jour, G; Shen, G; Underwood, CIM | 1 |
| Coleman, RE; Gillett, S; Hancock, BW; Hills, A; Ireson, J; Singh, K; Tidy, JA; Winter, MC | 1 |
| Chen, Y; Wang, K | 1 |
| Almeida, A; Bartosch, C; Cruz Pires, M; Peixinho, C | 1 |
| Braga, A; Mattar, R; Passos, JP; Signorini Filho, RC; Silva, ACBD; Sun, SY | 1 |
| Allias Montmayeur, F; Bolze, PA; Descargues, P; Devouassoux-Shisheboran, M; Golfier, F; Hajri, T; Lotz, JP; Massardier, J; You, B | 1 |
| Ai, L; Cao, Y; Li, K; Shen, C; Sun, D; Wu, H | 1 |
| Feng, F; Kong, Y; Li, Y; Ren, T; Wan, X; Xiang, Y; Yang, J; Zhao, J | 1 |
| Al-Saadi, R; Brok, J; de Camargo, B; de Krijger, RR; Drost, J; Godzinski, J; Graf, N; Groenendijk, A; Jiang, Y; Mavinkurve-Groothuis, AMC; Morosi, C; Perotti, D; Pritchard-Jones, K; Ramírez-Villar, GL; Rübe, C; Schenk, JP; Spreafico, F; Vaidya, SJ; van den Heuvel-Eibrink, MM; van Tinteren, H; Verschuur, AC; Vujanic, GM | 1 |
| Feng, F; Ji, M; Jiang, S; Ren, T; Wan, X; Xiang, Y; Yang, J; Zhao, J | 1 |
| Das, SK; Panthi, RC; Shahi, A | 1 |
| Bompas, E; Brugières, L; Castex, MP; Chevreau, C; Cleirec, M; Corvest, V; Duranteau, L; Entz-Werle, N; Filhon, B; Flandrin, J; Fresneau, B; Gaspar, N; Gentet, JC; Guimard, G; Jimenez, M; Laurence, V; Le Deley, MC; Lervat, C; Mansuy, L; Marec-Bérard, P; Pacquement, H; Pondrom, M; Rousset-Jablonski, C; Saumet, L; Tabone, MD; Taque, S; Toulmonde, M; Verité, C | 1 |
| Brennan, B; Fenwick, N; Gaspar, N; Gelderblom, H; Kirton, L; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
| Berkowitz, RS; Braga, A; Elias, KM; Freitas, F; Fülöp, V; Horowitz, NS; Jareemit, N; Maestá, I; Paiva, G; Ramírez, LAC; Therasakvichya, S | 1 |
| Gillett, S; Hapuarachi, B; Ireson, J; Romanowski, C; Singh, K; Tidy, JA; Winter, MC | 1 |
| Baloch, SS; Khan, SR; Moosajee, M; Samon, Z; Shahid, A; Shahzadi, M; Tariq, M | 1 |
36 review(s) available for dactinomycin and etoposide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment of "good risk" metastatic testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Humans; Male; Neoplasm Staging; Risk Factors; Testicular Neoplasms; Vinblastine | 1992 |
Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Vincristine | 1992 |
Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Multicenter Studies as Topic; Neoplasms, Germ Cell and Embryonal; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Testicular Neoplasms; Vinblastine; Vincristine | 1990 |
Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
Topics: Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Pregnancy; Prognosis; Severity of Illness Index; Trophoblastic Neoplasms; Uterine Neoplasms | 1991 |
Current concepts in clinical therapeutics: testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Dactinomycin; Dysgerminoma; Etoposide; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1987 |
[Current role of oncostatic chemotherapy in malignant testicular tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Male; Orchiectomy; Testicular Neoplasms; Vinblastine | 1987 |
[Chemotherapy of disseminated germ cell tumors of the testis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Lymphatic Metastasis; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1987 |
[New combination chemotherapy in refractory rhabdomyosarcoma of the prostate: a case report and review of the literature].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Peplomycin; Peptichemio; Prednisone; Prostatic Neoplasms; Rhabdomyosarcoma; Vincristine | 1987 |
The role of induction and maintenance chemotherapy in disseminated testicular non-seminomatous cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Male; Testicular Neoplasms; Vinblastine | 1984 |
High-risk metastatic gestational trophoblastic tumors. Current management.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Clinical Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Lung Neoplasms; Methotrexate; Neoplasm Staging; Pregnancy; Prognosis; Remission Induction; Risk Factors; Survival Rate; Thoracotomy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vaginal Neoplasms; Vincristine | 1994 |
[Improvement of survival of testicular cancer patients through chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Transplantation; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Male; Methotrexate; Survival Rate; Testicular Neoplasms; Vinblastine | 1995 |
[High-dose chemotherapy with autologous bone marrow transplantation or peripheral blood stem cell transplantation--testicular cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Dactinomycin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Testicular Neoplasms; Vinblastine | 1995 |
Brain metastasis from clear cell sarcoma of the kidney--a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Craniotomy; Dactinomycin; Doxorubicin; Etoposide; Fatal Outcome; Frontal Lobe; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Nephrectomy; Vincristine | 1993 |
[Etoposide (VP-16) in gynecologic malignancy].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Methotrexate; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1996 |
[Adjuvant chemotherapy of lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Lung Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Vincristine | 1987 |
Management of high-risk gestational trophoblastic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Humans; Liver Neoplasms; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dactinomycin; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Chemotherapy for trophoblastic disease: current standards.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Methotrexate; Neoplasm Staging; Pregnancy; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Melphalan; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyosarcoma; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Topotecan; Treatment Outcome; Vincristine | 2001 |
Treatment of gestational trophoblastic tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Methotrexate; Neoplasm Staging; Practice Guidelines as Topic; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
[Treatment of malignant ovarian germ cell tumor and sex cord tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Germinoma; Humans; Ovarian Neoplasms; Sex Cord-Gonadal Stromal Tumors; Vinblastine; Vincristine | 2002 |
[Gestational trophoblastic tumors and recent clinical information].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Contraceptives, Oral; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Pregnancy; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
Successful chemotherapy for melanotic neuroectodermal tumor of infancy in a baby.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Daunorubicin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Maxillary Neoplasms; Neuroectodermal Tumor, Melanotic; Treatment Outcome; Vinca Alkaloids | 2003 |
Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Life Tables; Male; Nasopharyngeal Neoplasms; Neoplasm Staging; Pennsylvania; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2003 |
Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Treatment Outcome; Vincristine | 2005 |
Primitive neuroectodermal tumor of the cervix uteri: a case report -- changing concepts in therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mesna; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive, Peripheral; Uterine Cervical Neoplasms; Vincristine | 2005 |
[Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Cranial Irradiation; Dactinomycin; Disease-Free Survival; Epirubicin; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Life Tables; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiation Injuries; Radiotherapy, Adjuvant; Reoperation; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Treatment of metastatic gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Vincristine | 2007 |
Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Craniotomy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Infant; Infant, Newborn; Injections, Spinal; Kaplan-Meier Estimate; Male; Prognosis; Prospective Studies; Rhabdoid Tumor; Spinal Neoplasms; Teratoma; Treatment Outcome; Vincristine | 2009 |
Bilateral Wilms' tumors: single-center experience with 22 cases and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Egypt; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Mesna; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nephrectomy; Retrospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2010 |
Postmenopausal choriocarcinoma: a rare case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Postmenopause; Vaginal Neoplasms; Vincristine | 2018 |
Multiple metastatic gestational trophoblastic disease after a twin pregnancy with complete hydatidiform mole and coexisting fetus, following assisted reproductive technology: Case report and literature review.
Topics: Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertilization in Vitro; Gestational Age; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hysterectomy; Lung Neoplasms; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Twin; Tomography, X-Ray Computed; Uterine Hemorrhage; Uterine Neoplasms; Vincristine | 2018 |
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2019 |
Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Paclitaxel; Placenta; Pregnancy; Quality of Life; Retrospective Studies; Vincristine | 2023 |
Review of current literature on gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Vincristine | 2023 |
68 trial(s) available for dactinomycin and etoposide
| Article | Year |
|---|---|
Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Methotrexate; Pregnancy; Prospective Studies; Risk Factors; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1992 |
Carboplatin and etoposide (CarE) combined with radiotherapy and vincristine, doxorubicin and cyclophosphamide (VAC) in limited small cell lung cancer. A phase II study.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Radiography; Time Factors; Treatment Outcome; Vincristine | 1992 |
POMB/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Humans; Male; Mediastinal Neoplasms; Mesonephroma; Methotrexate; Middle Aged; Prognosis; Retroperitoneal Neoplasms; Teratoma; Testicular Neoplasms; Time Factors; Vincristine | 1992 |
Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Multicenter Studies as Topic; Neoplasms, Germ Cell and Embryonal; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Testicular Neoplasms; Vinblastine; Vincristine | 1990 |
The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Randomized Controlled Trials as Topic; Regression Analysis; Remission Induction; Risk Factors; Testicular Neoplasms; Vinblastine | 1990 |
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Follow-Up Studies; Genital Neoplasms, Male; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Survival Analysis; Survival Rate; Vinblastine | 1991 |
[A randomized trial of PVB, VAB-6, BVP regimen versus PEB chemotherapy in patients with disseminated testicular tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Male; Prognosis; Survival Rate; Testicular Neoplasms; Vinblastine | 1991 |
High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Methotrexate; Neoplasm Metastasis; Pilot Projects; Pregnancy; Prognosis; Risk Factors; Severity of Illness Index; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1991 |
Ifosfamide in soft tissue sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Sarcoma; Soft Tissue Neoplasms | 1990 |
Vincristine, doxorubicin and cyclophosphamide with and without etoposide in limited small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Vincristine | 1990 |
Treatment of patients with poor prognosis anaplastic germ cell tumours (AGCT) of the testis and other sites.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Administration Schedule; Dysgerminoma; Etoposide; Humans; Male; Methotrexate; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms; Vincristine | 1987 |
A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Dysgerminoma; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Random Allocation; Testicular Neoplasms; Vinblastine | 1988 |
Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Chorionic Gonadotropin; Clinical Trials as Topic; Craniotomy; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Prognosis; Vincristine | 1989 |
Cyclic alternating polychemotherapy with or without upper and lower half-body irradiation in small cell anaplastic lung cancer. A randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Random Allocation; Time Factors; Vincristine | 1987 |
Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwes
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Radiotherapy; Random Allocation; Vincristine | 1987 |
No routine role for vincristine, adriamycin, and cyclophosphamide (VAC) or thoracic radiation therapy in extensive stage small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Lomustine; Lung Neoplasms; Random Allocation; Remission Induction; Vincristine | 1987 |
Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Leukopenia; Lung Neoplasms; Methotrexate; Random Allocation; Stomatitis; Vincristine | 1984 |
Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Germinoma; Humans; Male; Survival Analysis; Vinblastine | 1993 |
The Third Intergroup Rhabdomyosarcoma Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Prognosis; Remission Induction; Rhabdomyosarcoma; Survival Rate; United Kingdom; United States; Vincristine | 1995 |
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Middle Aged; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine | 1993 |
Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/PE).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Unknown Primary; Retrospective Studies; Vincristine | 1994 |
Treatment of endodermal sinus tumor in children using a regimen that lacks bleomycin.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Endodermal Sinus Tumor; Etoposide; Female; Humans; Infant; Treatment Outcome; Vincristine | 1996 |
[Clinical study of testicular cancer].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Germinoma; Humans; Ifosfamide; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Survival Rate; Vinblastine | 1996 |
The assessment of value of transvaginal ultrasound for monitoring of gestational trophoblastic disease treatment.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Monitoring, Physiologic; Ovary; Pregnancy; Trophoblastic Neoplasms; Ultrasonography; Uterine Neoplasms; Uterus | 1997 |
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 1998 |
Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Cyclophosphamide; Cyclosporine; Dactinomycin; Drug Interactions; Etoposide; Fever; Humans; Ifosfamide; Immunosuppressive Agents; Neutropenia; Patient Admission; Retrospective Studies; Sarcoma; Sepsis; Soft Tissue Neoplasms; Vincristine | 1998 |
Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Uterine Cervical Neoplasms; Vinblastine; Vincristine | 1998 |
Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Thorax; Vincristine | 1998 |
Role of chemotherapy in the treatment of infantile fibrosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fibrosarcoma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Mesna; Soft Tissue Neoplasms; Vincristine | 1999 |
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Epirubicin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 1999 |
[Results of chemotherapy and salvage surgery for advanced testicular cancer].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Remission Induction; Salvage Therapy; Seminoma; Testicular Neoplasms; Vinblastine | 1999 |
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Neoplasm Staging; Prognosis; Retrospective Studies; Rhabdomyosarcoma, Embryonal; Risk Factors; Vincristine | 2000 |
Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Disease-Free Survival; Etoposide; Female; Humans; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Salvage Therapy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 2000 |
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Europe; Humans; Ifosfamide; Incidence; Infant; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 2001 |
Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bronchiolitis Obliterans; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kidney Diseases; Life Tables; Male; Melphalan; Neoplasm Metastasis; Radiotherapy, Adjuvant; Remission Induction; Rhabdomyosarcoma; Sepsis; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Gastrointestinal Diseases; Germinoma; Hematologic Diseases; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Prognosis; Prospective Studies; Remission Induction; Seminoma; Survival Analysis; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vincristine | 2002 |
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma; Sarcoma, Ewing; Survival Rate; Treatment Failure; Vincristine | 2003 |
Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Prospective Studies; Risk Factors; Vincristine | 2003 |
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Salvage chemotherapy for high-risk gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Middle Aged; Risk Factors; Salvage Therapy; Treatment Outcome | 2004 |
EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Treatment Outcome | 2004 |
Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Infusions, Intravenous; Injections, Intramuscular; Leucovorin; Methotrexate; Recurrence; Remission Induction; Risk Factors; Treatment Outcome | 2005 |
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Teniposide; Treatment Outcome; Vincristine | 2005 |
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Infant, Newborn; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Teniposide; Vincristine | 2005 |
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Pelvic Bones; Radiotherapy, Adjuvant; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2006 |
Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Infusions, Intravenous; Male; Neoplasm Staging; Predictive Value of Tests; Prognosis; Rhabdomyosarcoma; Risk Assessment; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2006 |
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Neural Tube Defects; Neuroectodermal Tumors, Primitive; Proportional Hazards Models; Risk; Sarcoma, Ewing; Vincristine | 2007 |
Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2007 |
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Infant, Newborn; Kidney Neoplasms; Male; Neoplasm Staging; Recurrence; Wilms Tumor | 2008 |
GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Humans; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Recurrence; Treatment Outcome | 2007 |
Efficacy of the FAEV regimen in the treatment of high-risk, drug-resistant gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Treatment Outcome; Vincristine | 2007 |
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine | 2008 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Ifosfamide; Infant; Lung Neoplasms; Male; Neoplasm Staging; Prospective Studies; Sarcoma, Ewing; Vincristine | 2008 |
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Soft Tissue Neoplasms; Vincristine; Young Adult | 2009 |
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2009 |
Chemotherapy: The role of ifosfamide and etoposide in Ewing sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Metastasis; Radiography; Sarcoma, Ewing; Time Factors; Treatment Outcome; Tumor Burden; Vincristine | 2009 |
Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Infant; Middle Aged; Prognosis; Risk Factors; Sarcoma, Ewing; Vincristine | 2010 |
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Sarcoma, Ewing; Vincristine; Young Adult | 2011 |
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatr
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prognosis; Rhabdomyosarcoma; Sarcoma; Treatment Outcome; Vincristine | 2012 |
[Prospective multicentre study of chemotherapeutic regimen containing pirarubicin on the treatment of relapsed or refractory acute myeloid leukemia in adults].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Recurrence; Remission Induction | 2014 |
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Sarcoma, Ewing; Treatment Outcome; Vincristine; Young Adult | 2014 |
Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Neoplasm Staging; Risk Factors; Survival Rate; Treatment Outcome; Vincristine; Wilms Tumor | 2018 |
The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukopenia; Menstrual Cycle; Methotrexate; Middle Aged; Nausea; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult | 2020 |
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Busulfan; Child; Child, Preschool; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Male; Middle Aged; Sarcoma, Ewing; Vincristine; Young Adult; Zoledronic Acid | 2020 |
An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Rhabdomyosarcoma; Survival Rate; Time Factors; Vincristine | 2020 |
Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Neoplasm Recurrence, Local; Pregnancy; Vincristine | 2022 |
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 2023 |
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bone Neoplasms; Busulfan; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Melphalan; Sarcoma, Ewing; Vincristine | 2022 |
421 other study(ies) available for dactinomycin and etoposide
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Cell-based screen for identification of inhibitors of tubulin polymerization.
Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured | 1996 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6).
Topics: Animals; Antineoplastic Agents; Biological Transport, Active; CHO Cells; Cricetinae; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Leukotriene C4; Multidrug Resistance-Associated Proteins; Teniposide; Transfection | 2002 |
Antitumor agents. 1. Synthesis, biological evaluation, and molecular modeling of 5H-pyrido[3,2-a]phenoxazin-5-one, a compound with potent antiproliferative activity.
Topics: Antineoplastic Agents; Cell Division; DNA; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Intercalating Agents; Magnetic Resonance Spectroscopy; Models, Molecular; Oxazines; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured | 2002 |
Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; CD4-Positive T-Lymphocytes; Cells, Cultured; Doxorubicin; Drug Resistance, Neoplasm; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Lamivudine; Microbial Sensitivity Tests; Neoplasm Proteins; Reverse Transcriptase Inhibitors; Zidovudine | 2003 |
Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Topics: Antineoplastic Agents; Cell Division; Cell Line, Tumor; DNA; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Intercalating Agents; Isoquinolines; Magnetic Resonance Spectroscopy; Models, Molecular; Pyridines; Structure-Activity Relationship; Thiophenes | 2004 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Cell Membrane; Drug Resistance, Microbial; Drug Resistance, Multiple; Ligands; Models, Molecular | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Antitumor agents 7. Synthesis, antiproliferative activity and molecular modeling of new l-lysine-conjugated pyridophenoxazinones as potent DNA-binding ligands and topoisomerase IIα inhibitors.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Ligands; Linear Models; Lysine; Models, Molecular; Molecular Structure; Oxazines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2020 |
Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.
Topics: Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Leukemia L1210; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred DBA; Podophyllotoxin; Vincristine | 1976 |
Metastatic choriocarcinoma with coexistent term pregnancy following four recurrent consecutive moles.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Lung Neoplasms; Methotrexate; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms | 1992 |
[Magnetic resonance tomography in follow-up of hydatidiform mole].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Uterus | 1992 |
Primary treatment of pelvic osteosarcoma. Report of five cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fluid Therapy; Follow-Up Studies; Humans; Ifosfamide; Injections, Intra-Arterial; Lung Neoplasms; Osteosarcoma; Pelvic Bones; Radiotherapy Dosage; Survival Rate | 1992 |
Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Humans; Menstruation; Methotrexate; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovary; Reproduction; Retrospective Studies; Uterus; Vinblastine; Vincristine | 1992 |
Ovarian germ cell malignancies: the Yale University experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertility; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Salvage Therapy; Vinblastine; Vincristine | 1992 |
Successful treatment of a primary endodermal sinus tumor of the liver.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Hepatectomy; Humans; Liver Neoplasms; Mesonephroma; Methotrexate; Vincristine | 1992 |
Ewing's sarcoma: experience with 12 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine | 1992 |
[Treatment of primary therapy refractory choriocarcinoma using the EMA-CO protocol].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy, Vaginal; Kidney Neoplasms; Methotrexate; Nephrectomy; Pregnancy; Uterine Neoplasms; Vincristine | 1992 |
Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Combined Modality Therapy; Craniotomy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Methotrexate; Pregnancy; Survival Rate; Thoracotomy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1991 |
A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717).
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cell Line; Cisplatin; Cross Reactions; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Folic Acid; Humans; Leucovorin; Membrane Glycoproteins; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinazolines; RNA, Messenger; Thymidylate Synthase; Trimetrexate; Vincristine | 1991 |
Adult Wilms' tumor. Cisplatin and etoposide for relapse after adjuvant chemotherapy.
Topics: Adult; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Prognosis; Vincristine; Wilms Tumor | 1990 |
[A case of complete remission obtained with etoposide cis-platinum combination chemotherapy in advanced testicular cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Remission Induction; Testicular Neoplasms; Vinblastine | 1990 |
The UK Children's Cancer Study Group: testicular malignant germ cell tumours 1979-1988.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Chorionic Gonadotropin; Cisplatin; Clinical Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Infant; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Peptichemio; Prednisone; Testicular Neoplasms; United Kingdom; Vincristine | 1990 |
Respiratory failure due to choriocarcinoma: a study of 103 dyspneic patients.
Topics: Adult; Anemia; Blood Gas Analysis; Choriocarcinoma; Cyanosis; Dactinomycin; Drug Therapy, Combination; Dyspnea; Etoposide; Extracorporeal Membrane Oxygenation; Female; Humans; Hypertension, Pulmonary; Lung; Lung Neoplasms; Methotrexate; Pregnancy; Radiography; Respiratory Insufficiency; Risk Factors; Tachycardia; Uterine Neoplasms | 1990 |
Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Ovarian Neoplasms; Vincristine | 1990 |
Pancreatoblastoma: response to chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Vinblastine; Vincristine | 1991 |
Placental site trophoblastic tumor in a postmenopausal woman.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Menopause; Methotrexate; Middle Aged; Neoplasms; Placenta Diseases; Pregnancy; Trophoblastic Neoplasms | 1991 |
Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Humans; Ovarian Neoplasms; Reoperation; Survival Analysis; Vincristine | 1991 |
Improvement in survival from choriocarcinoma in Harare.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cause of Death; Choriocarcinoma; Dactinomycin; Etoposide; Female; Hospitals, Urban; Humans; Leucovorin; Methotrexate; Pregnancy; Prospective Studies; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Zimbabwe | 1991 |
Normal pregnancy after curative multiagent chemotherapy for choriocarcinoma with brain metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Primary Ovarian Insufficiency; Uterine Neoplasms | 1991 |
Circumvention of pleiotropic drug resistance in subcutaneous tumours in vivo with verapamil and clomipramine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Clomipramine; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Female; Male; Mice; Mice, Inbred AKR; Osteosarcoma; Verapamil; Vincristine | 1991 |
Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes.
Topics: Amsacrine; Animals; Cycloheximide; Dactinomycin; Dexamethasone; DNA; Electrophoresis; Etoposide; Flow Cytometry; Lymphocytes; Mitosis; Rats; Rats, Inbred Strains; Teniposide; Thymus Gland; Time Factors; Topoisomerase II Inhibitors | 1991 |
Small-cell lung cancer in elderly patients: the case for chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Survival Rate; Vincristine | 1991 |
Lactobacillus septicemia, an unusual complication during the treatment of metastatic choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lactobacillus acidophilus; Methotrexate; Ovarian Neoplasms; Pregnancy; Sepsis; Uterine Neoplasms; Uterus; Vagina; Vincristine | 1991 |
Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein.
Topics: Animals; Antineoplastic Agents; Arsenic; Arsenites; Blotting, Western; Carmustine; Cell Line; Cell Survival; Colchicine; Cricetinae; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Heat-Shock Proteins; Humans; Hydrogen Peroxide; Pentosyltransferases; Sodium Compounds; Teniposide; Vincristine | 1991 |
Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): a phase II study in advanced gastric carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Evaluation; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Remission Induction; Stomach Neoplasms; Vincristine | 1991 |
P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
Topics: Affinity Labels; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding, Competitive; Breast Neoplasms; Cricetinae; Cricetulus; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Humans; Membrane Glycoproteins; Neoplasm Proteins; Tumor Cells, Cultured; Verapamil; Vinblastine; Vindesine | 1990 |
Role of chemotherapy in pediatric pulmonary blastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Thoracic Neoplasms; Vincristine | 1990 |
Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Drug Evaluation; Etoposide; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Stomatitis; Testicular Neoplasms; Time Factors | 1990 |
Large cell carcinoma of the lung secreting human chorionic gonadotropin which responded to combination chemotherapy: case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Male; Methotrexate | 1990 |
Nasopharyngeal rhabdomyosarcoma presenting as a breast mass.
Topics: Adolescent; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Nasopharyngeal Neoplasms; Rhabdomyosarcoma; Tomography, X-Ray Computed; Vincristine | 1990 |
Subrenal capsule assay as a test to predict the effectiveness of chemotherapy in choriocarcinoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Lung Neoplasms; Methotrexate; Mice; Mice, Nude; Subrenal Capsule Assay; Vincristine | 1990 |
Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Dysgerminoma; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Time Factors; Vinblastine; Vomiting | 1985 |
Small cell carcinoma of the ovary: a rapidly lethal tumor occurring in the young.
Topics: Adolescent; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Microscopy, Electron; Neoplasm Metastasis; Ovarian Neoplasms; Vinblastine; Vincristine | 1985 |
Successful management of metastatic and primary germ cell tumors in the brain.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Tomography, X-Ray Computed; Vincristine | 1986 |
[Advanced non-seminoma germinal tumors of the testicle. Therapeutic strategy and method of action of chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1986 |
Current optimum management of anaplastic germ cell tumours of the testis and other sites.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Vincristine | 1986 |
Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Risk; Testicular Neoplasms; Vinblastine | 1987 |
Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II.
Topics: Animals; Bleomycin; Cell Line; Cell Survival; Cytarabine; Dactinomycin; DNA Topoisomerases, Type II; Doxorubicin; Drug Synergism; Etoposide; Fibrosarcoma; Glycoproteins; Hydroxyurea; Mice; Recombinant Proteins; Teniposide; Tumor Necrosis Factor-alpha | 1987 |
Fertility after chemotherapy for ovarian germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Fertility; Humans; Menstruation; Methotrexate; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovary; Vincristine | 1987 |
Altered renin and aldosterone excretion in patients treated for metastatic germ cell tumours.
Topics: Aldosterone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Kidney; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Renin; Testicular Neoplasms; Vinblastine | 1987 |
Pituitary and testicular hormonal function after treatment for germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Neoplasms, Germ Cell and Embryonal; Pituitary Gland; Testicular Neoplasms; Testis; Testosterone; Vinblastine | 1987 |
Fertility after chemotherapy for male and female germ cell tumours.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Fertility; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Menstruation; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Spermatogenesis; Testicular Neoplasms; Vincristine | 1987 |
Is ectopic production of human chorionic gonadotrophin (hCG) or alpha fetoprotein (AFP) by tumours a marker of chemosensitivity?
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Dactinomycin; Doxorubicin; Etoposide; Hormones, Ectopic; Humans; Leucovorin; Methotrexate; Neoplasms; Vincristine | 1986 |
Reassessment of the role of adjunctive surgical therapy in the treatment of advanced germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dysgerminoma; Etoposide; Humans; Lung Neoplasms; Lymph Node Excision; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Retroperitoneal Neoplasms; Testicular Neoplasms; Vinblastine; Vincristine | 1987 |
Extragonadal germ cell tumors. Clinicopathologic findings and treatment experience in 12 patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Vinblastine; Vincristine | 1988 |
Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Pneumonia; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 1988 |
Advanced seminoma: the role of chemotherapy and adjunctive surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Dysgerminoma; Etoposide; Humans; Male; Mediastinal Neoplasms; Prospective Studies; Remission Induction; Retroperitoneal Neoplasms; Testicular Neoplasms; Vinblastine | 1988 |
[Hypomagnesemia following chemotherapy of disseminated testicular tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Dysgerminoma; Etoposide; Humans; Magnesium; Male; Middle Aged; Teratoma; Testicular Neoplasms; Vinblastine | 1988 |
Clinical predictors of response in metastatic germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Male; Neoplasm Metastasis; Prognosis; Retrospective Studies; Testicular Neoplasms; Vinblastine | 1988 |
Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regime.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Dysgerminoma; Etoposide; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms; Vincristine | 1988 |
Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Vincristine | 1989 |
The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Methotrexate; Neoplasms, Germ Cell and Embryonal; Vincristine | 1989 |
Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Genital Neoplasms, Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Sacrococcygeal Region; Testicular Neoplasms; Vinblastine; Vincristine | 1989 |
Chemotherapeutic approaches to the treatment of testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Dactinomycin; Etoposide; Humans; Male; Platinum; Prognosis; Testicular Neoplasms; Vinblastine | 1988 |
[Clinical evaluation of chemotherapy in urologic cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Penile Neoplasms; Prognosis; Remission Induction; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vinblastine | 1989 |
Treatment of disseminated germ cell tumours of the testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Leukocyte Count; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Testis; Vinblastine; Vincristine | 1989 |
Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells.
Topics: Animals; Calcimycin; Cricetinae; Cricetulus; Dactinomycin; Deoxyglucose; Doxorubicin; Drug Resistance; Etoposide; Female; HSP70 Heat-Shock Proteins; Hypoxia; Membrane Proteins; Ovarian Neoplasms; Tumor Cells, Cultured; Vincristine | 1989 |
Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, dactinomycin, vincristine, and cyclophosphamide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1989 |
Isolation of two Chinese hamster ovary cell mutants hypersensitive to topoisomerase II inhibitors and cross-resistant to peroxides.
Topics: Amsacrine; Animals; Cell Line; Cell Survival; Cricetinae; Dactinomycin; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Etoposide; Female; Mitoxantrone; Mutation; Ovary; Teniposide; Topoisomerase II Inhibitors | 1989 |
Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Parity; Pregnancy; Prognosis; Remission Induction; Trophoblastic Neoplasms; Uterine Neoplasms | 1989 |
Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16.
Topics: Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dactinomycin; Daunorubicin; Doxorubicin; Drug Resistance; Etoposide; Gene Expression; Humans; Leukemia; Lymphoma; Membrane Glycoproteins; Mitoxantrone; RNA, Messenger; Tumor Cells, Cultured; Vinblastine; Vincristine; Vindesine | 1989 |
VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Chorionic Gonadotropin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Pregnancy; Uterine Neoplasms; Vincristine | 1985 |
[Role of chemotherapy in the treatment of cancer of the testis in adults].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Choriocarcinoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dermoid Cyst; Doxorubicin; Dysgerminoma; Etoposide; Humans; Lymphatic Metastasis; Male; Mesonephroma; Neoplasm Staging; Retroperitoneal Neoplasms; Teratoma; Testicular Neoplasms; Vinblastine | 1985 |
Chemotherapy for non-seminomatous germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Teratoma; Testicular Neoplasms; Vinblastine; Vincristine | 1985 |
A new combination chemotherapy for the treatment of endodermal sinus tumour.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Injections, Intravenous; Mesonephroma; Ovarian Neoplasms; Vinblastine; Vincristine | 1989 |
Treatment of choroidal metastasis from choriocarcinoma. Case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Choroid Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Remission Induction; Retinal Hemorrhage; Uterine Neoplasms; Vincristine | 1989 |
[Chemotherapy of high-risk trophoblastic neoplasia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Prognosis; Risk; Trophoblastic Neoplasms; Vincristine | 1987 |
Management of high-risk gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Risk Factors; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1987 |
Reinduction chemotherapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bacterial Outer Membrane Proteins; Bacterial Proteins; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Membrane Glycoproteins; Peptidyl-Dipeptidase A; Vincristine | 1987 |
EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Hydroxyurea; Methotrexate; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1988 |
Recombinant human tumor necrosis factor alone and with chemotherapeutic agents. Effect on nude mouse-supported human bladder cancer heterografts.
Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Dactinomycin; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Etoposide; Mice; Mice, Nude; Neoplasm Transplantation; Recombinant Proteins; Subrenal Capsule Assay; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 1989 |
Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chromosome Deletion; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Phenotype; Tumor Cells, Cultured; Verapamil; Vincristine | 1989 |
Relationship between myelosuppression and chemotherapeutic response in small cell bronchogenic carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Vincristine | 1985 |
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Prognosis; Risk; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1986 |
Invasive mole.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole, Invasive; Hysterectomy; Leucovorin; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 1986 |
[Treatment of microcytic carcinoma of the lung with vincristine, adriamycin, cyclophosphamide and VP-16].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Male; Vincristine | 1986 |
Chemotherapy for gestational trophoblastic tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Dactinomycin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Hydatidiform Mole; Luteinizing Hormone; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms | 1987 |
Tumor necrosis factor enhances the in vitro and in vivo efficacy of chemotherapeutic drugs targeted at DNA topoisomerase II in the treatment of murine bladder cancer.
Topics: Animals; Antineoplastic Agents; Dactinomycin; DNA Topoisomerases, Type II; Doxorubicin; Etoposide; Female; Glycoproteins; Macrophage Activation; Mice; Recombinant Proteins; Teniposide; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 1987 |
Term pregnancy after three trophoblastic disease events.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Neoplasms, Multiple Primary; Pregnancy; Uterine Neoplasms; Vincristine | 1988 |
[Basic and clinical study of anticancer effect of etoposide on choriocarcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Drug Evaluation; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Methotrexate; Pregnancy; Remission Induction; Tumor Cells, Cultured; Uterine Neoplasms | 1988 |
Intensive chemotherapy including cisplatin with or without etoposide for children with soft-tissue sarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasm Metastasis; Patient Compliance; Remission Induction; Rhabdomyosarcoma; Soft Tissue Neoplasms; Time Factors; Vincristine | 1987 |
[New combination chemotherapy against drug-resistant choriocarcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Drug Evaluation, Preclinical; Etoposide; Female; Humans; Methotrexate; Pregnancy; Remission Induction; Risk; Uterine Neoplasms | 1987 |
[Rhabdomyosarcoma of the prostate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Male; Middle Aged; Prostatic Neoplasms; Rhabdomyosarcoma; Vincristine | 1986 |
Current concepts in the management of paratesticular rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Infant; Lymph Node Excision; Lymphatic Metastasis; Lymphography; Male; Neoplasm Staging; Postoperative Complications; Rhabdomyosarcoma; Testicular Neoplasms; Vincristine | 1985 |
Further advances in the management of malignant teratomas of the testis and other sites.
Topics: alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Staging; Prognosis; Retroperitoneal Neoplasms; Teratoma; Testicular Neoplasms; Vincristine | 1983 |
Evaluation of toxicity of intravitreal antineoplastic drugs.
Topics: Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Cytarabine; Dactinomycin; Doxorubicin; Etoposide; Injections; Mitomycins; Rabbits; Retina; Vincristine; Vitreous Body | 1984 |
Poor-prognosis gestational trophoblastic disease: an update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Methotrexate; Pregnancy; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms | 1984 |
[Tumors of the vitelline sac located in the vagina in children. Apropos of 11 cases].
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Infant; Mesonephroma; Methotrexate; Vaginal Neoplasms | 1983 |
[Treatment of patients with trophoblastic tumors in the Academic Medical Center: 31 patients in 10 years, 1983-1992].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Pregnancy; Prognosis; Retrospective Studies; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1995 |
Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Male; Middle Aged; Prognosis; Seminoma; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1994 |
Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Salvage Therapy; Testicular Neoplasms; Transplantation, Autologous; Vinblastine | 1994 |
Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; DNA; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Germinoma; Humans; Leukocytes; Male; Middle Aged; Ovarian Neoplasms; Platinum; Spectrophotometry, Atomic; Testicular Neoplasms; Vinblastine | 1994 |
Brain metastases of gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Brain Neoplasms; Chlorambucil; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Palliative Care; Peptide Fragments; Pregnancy; Remission Induction; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 1994 |
Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Peptide Fragments; Pregnancy; Trophoblastic Neoplasms; Ultrasonography; Uterine Neoplasms; Vacuum Curettage; Vincristine | 1994 |
The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Genital Neoplasms, Male; Germinoma; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors; Vinblastine; Vincristine | 1994 |
[Extraosseous Ewing's sarcoma with thoracic localization].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Male; Sarcoma, Ewing; Thoracic Neoplasms; Tomography, X-Ray Computed; Vincristine | 1994 |
A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 1995 |
Recurrent gestational trophoblastic disease following in-vitro fertilization.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Embryo Transfer; Etoposide; Female; Fertilization in Vitro; Humans; Infertility, Female; Methotrexate; Peptide Fragments; Pregnancy; Recurrence; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1994 |
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dactinomycin; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Ifosfamide; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Tamoxifen; Tomography, X-Ray Computed; Vincristine | 1994 |
Germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Germinoma; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Orchiectomy; Salvage Therapy; Testicular Neoplasms; Vinblastine | 1994 |
Secondary tumours following etoposide containing therapy for germ cell cancer.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Germinoma; Humans; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Neoplasms, Second Primary; Testicular Neoplasms; Vincristine | 1995 |
[Experimental and clinical study on chemotherapy for cervical adenocarcinoma].
Topics: Aclarubicin; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycin; Neoplasm Transplantation; Uterine Cervical Neoplasms | 1995 |
Failure of normalization of alphafetoprotein levels following the successful treatment of teratoma: a diagnostic trap for the unwary.
Topics: Adult; Alcohol Drinking; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Orchiectomy; Teratoma; Thoracotomy; Vincristine | 1995 |
A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNA.
Topics: Actins; Apoptosis; Cell Cycle; Cycloheximide; Dactinomycin; DNA, Neoplasm; Etoposide; Evaluation Studies as Topic; Flow Cytometry; Humans; Leukemia; Microscopy, Confocal; Phalloidine; Propidium; Staining and Labeling; Tumor Cells, Cultured | 1995 |
[Combination chemotherapy with POMB/ACE (cisplatin, vincristine, methotrexate, bleomycin, actinomycin D, cyclophosphamide, etoposide) in advanced non-seminomatous testicular tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Endodermal Sinus Tumor; Etoposide; Humans; Lymphatic Metastasis; Male; Methotrexate; Remission Induction; Teratoma; Testicular Neoplasms; Vincristine | 1995 |
Gestational choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Postpartum Period; Pregnancy; Prognosis; Spinal Neoplasms; Uterine Neoplasms; Vincristine | 1995 |
Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Remission Induction; Salvage Therapy; Testicular Neoplasms; Vinblastine | 1993 |
Gestational trophoblastic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Hydatidiform Mole; Leucovorin; Methotrexate; Neoplasm Metastasis; Neoplasm Staging; Pregnancy; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1994 |
Interleukin-6 inhibits apoptosis of malignant plasma cells.
Topics: Apoptosis; Cell Line; Dactinomycin; Dexamethasone; DNA Damage; Doxorubicin; Etoposide; Humans; In Vitro Techniques; Interleukin-6; Multiple Myeloma; Plasma Cells; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2 | 1995 |
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 11; Combined Modality Therapy; Dactinomycin; DNA-Binding Proteins; Etoposide; Female; Genes; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Whole-Body Irradiation | 1995 |
[Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Dactinomycin; Drug Administration Schedule; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Methotrexate; Middle Aged | 1994 |
bis(2,6-dioxopiperaxine) derivatives, topoisomerase II inhibitors which do not form a DNA cleavable complex, induce thymocyte apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cells, Cultured; Cycloheximide; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Gene Expression Regulation; Male; Mice; Mice, Inbred BALB C; Nucleic Acid Conformation; Piperazines; Razoxane; Thymus Gland; Topoisomerase I Inhibitors | 1994 |
Etoposide induces programmed death in neurons cultured from the fetal rat central nervous system.
Topics: Animals; Apoptosis; Cells, Cultured; Cerebral Cortex; Cycloheximide; Dactinomycin; DNA; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Kinetics; Neurons; Rats; Rats, Wistar; Time Factors | 1994 |
EMACO in high risk gestational trophoblast disease--the Australian experience. Gestational Trophoblast Subcommittee, Clinical Oncological Society of Australia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Australia; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Pregnancy; Risk; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1994 |
Chemotherapy combined with surgery in the treatment of gestational trophoblastic disease (GTD).
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Hydatidiform Mole; Hydroxyurea; Hysterectomy; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pregnancy; Salvage Therapy; Thoracotomy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Hemorrhage; Uterine Neoplasms; Vincristine | 1993 |
[A study of first and second line chemotherapies in gestational choriocarcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Pregnancy; Prognosis; Uterine Neoplasms; Vincristine | 1993 |
Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Methotrexate; Pregnancy; Prognosis; Remission Induction; Risk Factors; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1994 |
Changes in nuclear chromatin precede internucleosomal DNA cleavage in the induction of apoptosis by etoposide.
Topics: Apoptosis; Cell Nucleus; Cells, Cultured; Chromatin; Cycloheximide; Dactinomycin; DNA; Endonucleases; Etoposide; Flow Cytometry; Nucleosomes; Zinc | 1994 |
[Intensive chemotherapy for alveolar soft part sarcoma with lung metastasis in a child].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1993 |
Chemotherapy in the management of infantile fibrosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Fibrosarcoma; Humans; Ifosfamide; Infant; Infant, Newborn; Karyotyping; Leg; Male; Remission Induction; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 1993 |
Liver metastases of gestational trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 1993 |
Pulmonary hypertension--a rare presentation of choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hypertension, Pulmonary; Leucovorin; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1993 |
[Pathology and clinical aspects of peripheral neuroectodermal tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lung Neoplasms; Male; Neuroectodermal Tumors, Primitive, Peripheral; Neurofilament Proteins; Pancoast Syndrome; Vincristine | 1993 |
Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1993 |
Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dactinomycin; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies; Sarcoma, Kaposi; Skin Neoplasms; South Africa; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine | 1995 |
BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells.
Topics: Apoptosis; Camptothecin; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; DNA Damage; DNA, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Puromycin; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Frontal Lobe; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms; Vincristine | 1996 |
Metastatic cerebral choriocarcinoma coexistent with a viable pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Vincristine | 1996 |
A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Hydatidiform Mole; Injections, Intramuscular; Methotrexate; Pregnancy; Remission Induction; Uterine Neoplasms; Vincristine | 1996 |
Heat shock proteins increase resistance to apoptosis.
Topics: Animals; Apoptosis; Camptothecin; Cell Line; Cell Survival; Dactinomycin; DNA Damage; Etoposide; Fibrosarcoma; Heat-Shock Proteins; Heat-Shock Response; Humans; Mice; Monocytes; Tumor Cells, Cultured | 1996 |
Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dactinomycin; Disease Progression; Etoposide; Follow-Up Studies; Germinoma; Humans; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Retroperitoneal Space; Retrospective Studies; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1996 |
[In vitro chemosensitivity test for seven undifferentiated thyroid carcinoma cell lines using MTT assay].
Topics: Antineoplastic Agents; Bleomycin; Carcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Humans; Methotrexate; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Tumor Cells, Cultured; Vincristine | 1996 |
[Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 1995 |
Chemotherapy for ovarian germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Germinoma; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Salvage Therapy; Survival Rate; Vincristine | 1996 |
Metastatic choroidal choriocarcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Choroid Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Fatal Outcome; Female; Humans; Methotrexate; Pregnancy; Uterine Neoplasms | 1996 |
Persistent partial molar pregnancy. A report of uterus-preserving treatment and follow-up with magnetic resonance imaging.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 1996 |
Unusual presentation of a metastatic choriocarcinoma following a full term pregnancy: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Etoposide; Fatal Outcome; Female; Humans; Liver Neoplasms; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 1996 |
Gestational choriocarcinoma metastatic to the brain treated successfully by stereotactic radiosurgery and chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Radiosurgery; Tomography, X-Ray Computed; Treatment Outcome; Uterine Neoplasms; Vincristine | 1996 |
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Incidence; Methotrexate; Middle Aged; Neoplasms, Second Primary; Pregnancy; Time Factors; Trophoblastic Neoplasms; Uterine Neoplasms | 1996 |
Gestational trophoblastic disease presenting as a large metastasis to the finger.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Fingers; Humans; Leucovorin; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1996 |
Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells.
Topics: Antioxidants; Camptothecin; Cell Line; Cycloheximide; Dactinomycin; Daunorubicin; DNA; DNA Damage; DNA Topoisomerases, Type I; Etoposide; HIV-1; NF-kappa B; Nucleic Acid Synthesis Inhibitors; Poly(ADP-ribose) Polymerase Inhibitors; Topoisomerase I Inhibitors; Transcriptional Activation; Virus Activation | 1996 |
Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caenorhabditis elegans Proteins; Calcium-Calmodulin-Dependent Protein Kinases; Caspase 1; Caspases; Cysteine Endopeptidases; Dactinomycin; Enzyme Activation; Enzyme Inhibitors; Etoposide; fas Receptor; Helminth Proteins; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; MAP Kinase Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Protease Inhibitors; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; Protein-Tyrosine Kinases; Pyridines; Serpins; Signal Transduction; Sorbitol; Transcription, Genetic; Viral Proteins | 1997 |
Hepatic angiosarcoma in a child: successful therapy with surgery and adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hemangiosarcoma; Humans; Ifosfamide; Liver Neoplasms; Vincristine | 1997 |
The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Retrospective Studies; Trophoblastic Neoplasms; Uterine Neoplasms | 1997 |
Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Endodermal Sinus Tumor; Etoposide; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Seminoma; Teratoma; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1997 |
Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus.
Topics: Amsacrine; Antineoplastic Agents; Base Sequence; Cell Line; Dactinomycin; DNA Damage; DNA, Neoplasm; Doxorubicin; Etoposide; Genes, abl; Humans; Leukemia, Myeloid, Acute; Molecular Sequence Data; Monocytes; Restriction Mapping; Topoisomerase II Inhibitors; Translocation, Genetic | 1997 |
Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome; Vinblastine | 1997 |
Visual pathway glioma: an erratic tumour with therapeutic dilemmas.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Cranial Nerve Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Female; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Optic Chiasm; Optic Nerve Diseases; Vincristine; Visual Cortex | 1997 |
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Methotrexate; Middle Aged; Pregnancy; Risk; Risk Factors; Survival Analysis; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1997 |
Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Germinoma; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Survival Rate; Testicular Neoplasms; Vincristine | 1997 |
Inhibition of DNA unwinding and ATPase activities of human DNA helicase II by chemotherapeutic agents.
Topics: Adenosine Triphosphatases; Amsacrine; Antineoplastic Agents; Aphidicolin; Camptothecin; Dactinomycin; Daunorubicin; DNA; DNA Helicases; Ellipticines; Enzyme Inhibitors; Ethidium; Etoposide; Genistein; Humans; Isoflavones; Nogalamycin; Novobiocin; Topoisomerase I Inhibitors | 1997 |
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leg; Male; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine | 1997 |
POMB/ACE chemotherapy for mediastinal germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Germinoma; Humans; Male; Mediastinal Neoplasms; Methotrexate; Treatment Outcome; Vincristine | 1997 |
POMB/ACE chemotherapy for mediastinal germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Follow-Up Studies; Germinoma; Humans; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Seminoma; Survival Rate; Treatment Outcome; Vincristine | 1997 |
Etoposide-induced PC12 cell death: apoptotic morphology without oligonucleosomal DNA fragmentation or dependency upon de novo protein synthesis.
Topics: Analysis of Variance; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cycloheximide; Dactinomycin; DNA Fragmentation; Etoposide; Immunohistochemistry; Nerve Growth Factors; Nucleosomes; PC12 Cells; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats | 1997 |
[A case of primary mediastinal choriocarcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Mediastinal Neoplasms; Methotrexate | 1997 |
Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Binding Sites; Biological Transport; Cell Line; Cell Membrane; Colchicine; Cricetinae; Cricetulus; Dactinomycin; Daunorubicin; Doxorubicin; Etoposide; Fluorescence; Fluorescent Dyes; Kinetics; Liposomes; Protein Binding; Quercetin; Rhodamine 123; Rhodamines; Vinblastine | 1997 |
Management of stage II seminoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dactinomycin; Etoposide; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Seminoma; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1998 |
Metastatic placental site trophoblastic tumor: long-term remission in a patient treated with EMA/CO chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Radiography; Remission Induction; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vaginal Neoplasms; Vincristine | 1998 |
Contribution of gene-specific lesions, DNA-replication-associated damage, and subsequent transcriptional inhibition in topoisomerase inhibitor-mediated apoptosis in lymphoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Transformation, Viral; Chickens; Dactinomycin; DNA Damage; DNA Replication; DNA, Ribosomal; Etoposide; Genes, myc; Kinetics; Lymphoma, B-Cell; Lymphoma, T-Cell; Topoisomerase I Inhibitors; Transcription, Genetic; Tumor Cells, Cultured | 1998 |
Double high-dose chemotherapy with autologous peripheral stem cell rescue in relapsed Wilms' tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Salvage Therapy; Vincristine; Wilms Tumor | 1997 |
Management of resistant gestational trophoblastic tumors.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leucovorin; Methotrexate; Pregnancy; Risk Factors; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
Inhibition of pea chloroplast DNA helicase unwinding and ATPase activities by DNA-interacting ligands.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Amsacrine; Camptothecin; Chloroplasts; Dactinomycin; Daunorubicin; DNA Helicases; Ellipticines; Ethidium; Etoposide; Genistein; Hydrolysis; Intercalating Agents; Ligands; Nogalamycin; Novobiocin; Pisum sativum | 1998 |
Teratomas in infancy and childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Prognosis; Radiotherapy Dosage; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Teratoma; Vincristine | 1998 |
Glucocorticoid pretreatment reduces the cytotoxic effects of a variety of DNA-damaging agents on rat tibial growth-plate chondrocytes in vitro.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carboplatin; Cell Division; Chondrocytes; Cisplatin; Dactinomycin; Dexamethasone; Drug Interactions; Etoposide; Female; Male; Prednisolone; Rats; Tibia | 1998 |
Chemotherapeutic agents used in the treatment of childhood malignancies have direct effects on growth plate chondrocyte proliferation.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; Cell Cycle; Cell Division; Cells, Cultured; Chondrocytes; Cisplatin; Dactinomycin; Dexamethasone; Etoposide; Growth Plate; Male; Mercaptopurine; Methotrexate; Prednisolone; Rats; Rats, Sprague-Dawley; Thioguanine | 1998 |
Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors.
Topics: Amsacrine; Apoptosis; bcl-2-Associated X Protein; Camptothecin; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cycloheximide; Dactinomycin; DNA Damage; DNA Topoisomerases, Type I; DNA, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; Insulin-Like Growth Factor Binding Protein 3; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Chorionic Gonadotropin; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Methotrexate; Pregnancy; Remission Induction; Risk Factors; Trophoblastic Neoplasms; Uterine Neoplasms | 1998 |
Necrosis of myometrial choriocarcinoma with fulminating sepsis complicating chemotherapy for trophoblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Myometrium; Necrosis; Neoplasms, Multiple Primary; Pregnancy; Remission Induction; Sepsis; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
The management of high-risk gestational trophoblastic tumours (GTT).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Pregnancy; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Korea; Methotrexate; Pregnancy; Proportional Hazards Models; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years.
Topics: Adult; Antineoplastic Agents; Choriocarcinoma; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Hydroxyurea; Leucovorin; Menopause, Premature; Mercaptopurine; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors; Trophoblastic Neoplasms | 1998 |
Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage.
Topics: Animals; Cell Cycle; Cell Line; Cell Nucleus; Chromatin; Cycloheximide; Dactinomycin; DNA Damage; DNA, Single-Stranded; Etoposide; Fibroblasts; Gamma Rays; Humans; Kinetics; Mammals; Meiosis; Mitomycin; Nuclear Proteins; Rats; Recombinant Proteins; Sensitivity and Specificity; Xeroderma Pigmentosum | 1999 |
Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?
Topics: Adolescent; Adult; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Middle Aged; Patient Compliance; Pregnancy; Prognosis; Retrospective Studies; Risk Assessment; Trophoblastic Neoplasms; Uterine Neoplasms | 1999 |
The presentation and management of post-partum choriocarcinoma.
Topics: Adult; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Postpartum Hemorrhage; Postpartum Period; Pregnancy; Retrospective Studies; Uterine Neoplasms; Vincristine | 1999 |
Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death.
Topics: Amino Acid Chloromethyl Ketones; Antibodies, Monoclonal; Apoptosis; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; Dactinomycin; Enzyme Activation; Etoposide; fas Receptor; HL-60 Cells; Humans; Jurkat Cells; Neoplasms; Oncogenes; Staurosporine | 1998 |
Caspase-dependent proteolysis of integral and peripheral proteins of nuclear membranes and nuclear pore complex proteins during apoptosis.
Topics: Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Chromatin; Cysteine Proteinase Inhibitors; Dactinomycin; DNA-Binding Proteins; Etoposide; Glycoproteins; HeLa Cells; Humans; Membrane Proteins; Nuclear Envelope; Nuclear Pore Complex Proteins; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Oligopeptides; Serine Proteinase Inhibitors; Tosyllysine Chloromethyl Ketone; Tumor Cells, Cultured | 1999 |
The influence of radiation and chemotherapy-related DNA strand breaks on carcinogenesis: an evaluation.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Dactinomycin; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Etoposide; Leukemia, Experimental; Methotrexate; Mice; Tumor Cells, Cultured; Vincristine | 1999 |
Clinical assessment of EMA/CO induced DNA damage in peripheral blood lymphocytes of high-risk gestational trophoblastic tumor patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; DNA Damage; Etoposide; Female; Humans; Lymphocytes; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Vincristine | 1999 |
Permanent cell cycle arrest in asynchronously proliferating normal human fibroblasts treated with doxorubicin or etoposide but not camptothecin.
Topics: Antineoplastic Agents; Camptothecin; Cell Cycle; Cell Division; Cell Survival; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dactinomycin; DNA Damage; Doxorubicin; Etoposide; Fibroblasts; Humans; Tumor Suppressor Protein p53 | 1999 |
Collapse of the inner mitochondrial transmembrane potential is not required for apoptosis of HL60 cells.
Topics: Apoptosis; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Caspase 3; Caspases; Cell Nucleus; Cell Size; Cytochrome c Group; Dactinomycin; DNA Fragmentation; Enzyme Activation; Etoposide; Fluorescent Dyes; HL-60 Cells; Humans; Intracellular Membranes; Jurkat Cells; Membrane Potentials; Mitochondria; Oxidative Phosphorylation; Phosphatidylserines; Poly(ADP-ribose) Polymerases; Staurosporine | 1999 |
High-dose chemotherapy as primary treatment for poor-risk germ-cell tumors: the Memorial Sloan-Kettering experience (1988-1999).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cancer Care Facilities; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Germinoma; Humans; Male; New York City; Retrospective Studies; Salvage Therapy; Survival Rate; Testicular Neoplasms; Transplantation, Autologous; Vinblastine | 1999 |
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Italy; L-Lactate Dehydrogenase; Male; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Retrospective Studies; Sarcoma, Ewing; Vincristine | 2000 |
Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic plac
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Placenta; Pregnancy; Remission Induction; Risk Factors; Survival Rate; Trophoblastic Neoplasms; Uterine Neoplasms | 2000 |
Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Transfusion; Chi-Square Distribution; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Dactinomycin; Etoposide; Female; Fever; Humans; Ifosfamide; Male; Neutropenia; Pilot Projects; Platelet Transfusion; Retrospective Studies; Sarcoma; Sepsis; Treatment Outcome; Vincristine | 2000 |
Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals.
Topics: Androstadienes; Antineoplastic Agents; Apigenin; Apoptosis; bcl-Associated Death Protein; bcl-X Protein; Camptothecin; Carrier Proteins; Cell Survival; Chromones; Cycloheximide; Dactinomycin; Dimerization; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Flavonoids; Genes, bcl-2; HL-60 Cells; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mitoxantrone; Morpholines; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Sirolimus; Wortmannin | 2000 |
Proteasome activation as a critical event of thymocyte apoptosis.
Topics: Acetylcysteine; Amino Acid Chloromethyl Ketones; Animals; Antioxidants; Apoptosis; Caspase Inhibitors; Caspases; Catalase; Cells, Cultured; Cysteine Endopeptidases; Dactinomycin; Dexamethasone; Enzyme Activation; Etoposide; fas Receptor; Female; Mice; Mice, Inbred BALB C; Mitochondria; Multienzyme Complexes; Proteasome Endopeptidase Complex; T-Lymphocytes | 2000 |
Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Databases as Topic; England; Etoposide; Female; Follow-Up Studies; Humans; Hydatidiform Mole; Leucovorin; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Registries; Salvage Therapy; Time Factors; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 2000 |
Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Retrospective Studies; Trophoblastic Neoplasms; Uterine Neoplasms | 2000 |
Chemotherapy of gestational trophoblastic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2000 |
Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Dysgerminoma; Endodermal Sinus Tumor; Etoposide; Female; Fertility; Follow-Up Studies; Germinoma; Humans; Leucovorin; Menstruation; Methotrexate; Ovarian Neoplasms; Remission Induction; Reproduction; Vincristine | 2000 |
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Teratoma; Testicular Neoplasms; Treatment Outcome; Vinblastine; Vincristine | 2000 |
[Results of treatment for germ cell tumor--dose intensity of chemotherapy and residual masses after chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Germinoma; Humans; Male; Middle Aged; Neoplasm, Residual; Prognosis; Survival Rate; Testicular Neoplasms; Vinblastine | 2000 |
Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Radiation Pneumonitis; Radiotherapy; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53.
Topics: Acridine Orange; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Separation; Cells, Cultured; Cellular Senescence; Cisplatin; Cysteine Endopeptidases; Dactinomycin; DNA Damage; Electrophoresis, Polyacrylamide Gel; Etoposide; Fibroblasts; Flow Cytometry; Fluorescent Dyes; Humans; Models, Biological; Multienzyme Complexes; Necrosis; Nucleic Acid Synthesis Inhibitors; Proteasome Endopeptidase Complex; Time Factors; Transfection; Tumor Suppressor Protein p53; Ultraviolet Rays | 2001 |
Adjuvant hysterectomy in low-risk gestational trophoblastic disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Methotrexate; Middle Aged; Pregnancy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms | 2001 |
DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis.
Topics: Apoptosis; Cell Nucleus; Cell Survival; Cycloheximide; Dactinomycin; Deoxyribonuclease I; DNA; DNA Fragmentation; Etoposide; fas Receptor; Gene Targeting; Humans; Jurkat Cells; Kinetics; Nucleosomes; Paclitaxel; Transfection; Tumor Cells, Cultured | 2001 |
[Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumour].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Hydatidiform Mole, Invasive; Methotrexate; Middle Aged; Pregnancy; Uterine Neoplasms; Vincristine | 1999 |
Metastatic placental site trophoblastic tumor. Report of a case with complete response to chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Remission Induction; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2001 |
Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene.
Topics: Adenoviridae; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Northern; Dactinomycin; DNA Damage; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Gene Expression Regulation; Humans; Immunoblotting; Membrane Glycoproteins; Nucleic Acid Synthesis Inhibitors; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; TNF-Related Apoptosis-Inducing Ligand; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2001 |
Comparison of the properties of human breast cancer cells: MCF-7 and MCF-7 cells selected for resistance to etoposide.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Humans; Leukotriene Antagonists; Propionates; Protein Synthesis Inhibitors; Quinolines; Tumor Cells, Cultured; Vasodilator Agents; Verapamil; Vinblastine | 2001 |
Metastatic placental site trophoblastic tumors: clinical aspects of two unique cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2001 |
Central nervous system involvement in gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Prospective Studies; Survival Analysis; Tomography, X-Ray Computed; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2001 |
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Catechols; Child; Chromosome Breakage; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Ifosfamide; Isoenzymes; Models, Genetic; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms, Second Primary; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy, Adjuvant; Recombination, Genetic; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Transcription Factors; Transcriptional Elongation Factors; Translocation, Genetic; Vincristine | 2001 |
Serum creatine kinase levels parallel the clinical course for rhabdomyomatous Wilms tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Creatine Kinase; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Mesna; Neoplasm Recurrence, Local; Nephrectomy; Reference Standards; Rhabdomyoma; Vincristine; Wilms Tumor | 2001 |
Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis.
Topics: Annexin A5; Apoptosis; bcl-X Protein; Caspase 3; Caspases; Cell Death; Cell Line; Cell Survival; Dactinomycin; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Etoposide; Fibroblast Growth Factor 2; Flavonoids; Flow Cytometry; Humans; MAP Kinase Kinase Kinase 1; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Binding; Protein Biosynthesis; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Retroviridae; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Up-Regulation | 2002 |
Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Clinical Protocols; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Methotrexate; Pregnancy; Risk; Survival Analysis; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
Choriocarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hysterectomy; Lung Neoplasms; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
Postoperative radiotherapy in the treatment of Ewing tumors: influence of the interval between surgery and radiotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Data Interpretation, Statistical; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Pilot Projects; Postoperative Care; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Time Factors; Vincristine | 2002 |
Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cause of Death; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
Differential influence of etoposide on two caspase-2 mRNA isoforms in leukemic cells.
Topics: Alternative Splicing; Apoptosis; Apoptosis Regulatory Proteins; Caspase 2; Caspases; Cysteine Endopeptidases; Dactinomycin; Enzyme Induction; Enzyme Precursors; Etoposide; Exons; Gene Expression Regulation, Leukemic; Genes, bcl-2; HL-60 Cells; Humans; Leukemia, Monocytic, Acute; Leukemia, Promyelocytic, Acute; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Protein Biosynthesis; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; U937 Cells | 2002 |
Clinical characteristics of gestational trophoblastic disease at a single institute.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2002 |
[Management of advanced seminoma: retrospective study of 96 patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm, Residual; Prognosis; Radiotherapy, Adjuvant; Retroperitoneal Neoplasms; Retrospective Studies; Seminoma; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2002 |
Coexisting true hermaphroditism and partial hydatidiform mole developing metastatic gestational trophoblastic tumors. A case report.
Topics: Abortion, Therapeutic; Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Disorders of Sex Development; Etoposide; Female; Fetus; Humans; Hydatidiform Mole; Lung Neoplasms; Magnetic Resonance Imaging; Male; Methotrexate; Mosaicism; Neoplasms, Multiple Primary; Pregnancy; Pregnancy Complications, Neoplastic; Radiography; Trophoblastic Neoplasms; Uterine Neoplasms | 2002 |
[Salvage thermochemotherapy in advanced refractory malignant tumors in children].
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Interleukin-2; Male; Melphalan; Monitoring, Immunologic; Neoplasms; Neuroleptanalgesia; Salvage Therapy; Time Factors; Vincristine | 2002 |
Case of PSTT treated with chemotherapy followed by open uterine tumor resection to preserve fertility.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertility; Humans; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2002 |
Comparison of the TUNEL, lamin B and annexin V methods for the detection of apoptosis by flow cytometry.
Topics: Annexin A5; Apoptosis; Dactinomycin; DNA Fragmentation; Enzyme Inhibitors; Etoposide; Flow Cytometry; Fluorescent Antibody Technique, Indirect; HL-60 Cells; Humans; In Situ Nick-End Labeling; Kinetin; Lamin Type B; Purines; Sensitivity and Specificity | 2002 |
Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Graft vs Tumor Effect; Head and Neck Neoplasms; Humans; Ifosfamide; Immunosuppressive Agents; Neoplasm Recurrence, Local; Nimustine; Peripheral Blood Stem Cell Transplantation; Rhabdomyosarcoma; Transplantation Conditioning; Vincristine | 2003 |
Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Remission Induction; Time Factors | 2003 |
The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair.
Topics: Activating Transcription Factor 2; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cisplatin; Cyclic AMP Response Element-Binding Protein; Dactinomycin; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Gastrointestinal Agents; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Phenotype; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured; Vitamin U | 2003 |
[Cerebral metastasis in choriocarcinoma a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blindness; Brain Neoplasms; Cerebral Angiography; Choriocarcinoma; Chorionic Gonadotropin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Intracranial Aneurysm; Leucovorin; Methotrexate; Pregnancy; Prognosis; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed; Uterine Neoplasms; Vincristine | 2003 |
Epithelioid trophoblastic tumour: report of a case in the fallopian tube.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Disease-Free Survival; Doxorubicin; Epidermal Growth Factor; Epithelioid Cells; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Hysterectomy; Immunohistochemistry; Inhibins; Leucovorin; Methotrexate; Pregnancy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2003 |
Nephroblastomatosis update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Kidney Neoplasms; Male; Vincristine; Wilms Tumor | 2003 |
Pregnancy after EMA/CO for gestational trophoblastic disease: a report from The Netherlands.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Attitude to Health; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Methotrexate; Middle Aged; Motivation; Netherlands; Pregnancy; Pregnancy Outcome; Prognosis; Uterine Neoplasms; Vincristine | 2003 |
[Evaluation of surgical resection of pulmonary metastasis of trophoblastic tumour].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole, Invasive; Lung Neoplasms; Male; Methotrexate; Middle Aged; Pneumonectomy; Pregnancy; Prognosis; Retrospective Studies; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2003 |
The DNA damage-induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspases.
Topics: Adenocarcinoma; Adenoviridae; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Apoptotic Protease-Activating Factor 1; Caspase Inhibitors; Caspases; Cell Transplantation; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enzyme Activation; Enzyme Inhibitors; Etoposide; Fibroblasts; Gene Deletion; Humans; Mice; Mice, SCID; Pancreatic Neoplasms; Proteins; Proto-Oncogene Proteins c-bcl-2; Transplantation, Heterologous; Tumor Cells, Cultured; Ultraviolet Rays | 2003 |
Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Infertility, Female; Infertility, Male; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Vincristine | 2003 |
Dual role of NF-kappaB in apoptosis of THP-1 cells during treatment with etoposide and lipopolysaccharide.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase Inhibitors; Caspases; Cycloheximide; Dactinomycin; Drug Therapy, Combination; Enzyme Inhibitors; Etoposide; Humans; Inhibitor of Apoptosis Proteins; Leukemia; Lipopolysaccharides; NF-kappa B; Protein Synthesis Inhibitors; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tosyllysine Chloromethyl Ketone; Tumor Cells, Cultured; X-Linked Inhibitor of Apoptosis Protein | 2004 |
Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Dactinomycin; Diagnosis, Differential; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Hysterectomy; Methotrexate; Pregnancy; Salvage Therapy; Trophoblastic Neoplasms; Uterine Neoplasms | 2004 |
Feasibility of central co-ordinated EMA/CO for gestational trophoblastic disease in the Netherlands.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2004 |
Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Graft Survival; Hematopoiesis; Humans; Idarubicin; Ifosfamide; Infections; Male; Middle Aged; Multiple Myeloma; Neutropenia; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation | 2004 |
Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53.
Topics: Apoptosis; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Survival; Coloring Agents; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Endopeptidases; Enzyme Inhibitors; Etoposide; Gamma Rays; Humans; Mass Spectrometry; Models, Biological; Phosphotransferases (Alcohol Group Acceptor); Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Transcription, Genetic; Tumor Suppressor Protein p53; Up-Regulation | 2004 |
Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[[dimethylcarbamoyl]oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia cells occurs via the c-Jun NH2-terminal kinase-dependent phosphorylation and inactivation o
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Carbazoles; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; K562 Cells; Leukemia; Leukocytes, Mononuclear; Mitogen-Activated Protein Kinases; Oxazepines; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Subcellular Fractions; Tumor Cells, Cultured; Ultraviolet Rays | 2004 |
Relative cytotoxicity values at the lowest effective concentration for 12 positive chemicals in the in vitro micronucleus test utilizing Chinese hamster ovary cells.
Topics: Animals; Benz(a)Anthracenes; Bleomycin; Cell Count; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Griseofulvin; Hazardous Substances; Hydrogen Peroxide; Hydroxyurea; Methyl Methanesulfonate; Mitomycin; Phenol; Vinblastine | 2004 |
Management of patients with metastatic gestational trophoblastic tumor.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors | 2004 |
Placental site trophoblastic tumor: an overview.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertility; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Placenta Diseases; Pregnancy; Retrospective Studies; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2004 |
Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Treatment Failure; Vincristine | 2004 |
Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent.
Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dexamethasone; Etoposide; Female; Fetus; Humans; Ifosfamide; Infant, Newborn; Kidney Neoplasms; Lumbar Vertebrae; Lung Neoplasms; Neoplasm Recurrence, Local; Patient Dropouts; Polyradiculopathy; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Spinal Cord Compression; Vincristine; Wilms Tumor | 2004 |
[A case of retroperitoneal neuroblastoma in an adult with extensive bone marrow metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Carboplatin; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Neuroblastoma; Paraplegia; Retroperitoneal Neoplasms; Skull Neoplasms; Vincristine | 2004 |
Chemoresistant placental site trophoblastic tumor with hilar lymph node metastasis: an unusual site of involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphatic Metastasis; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Vincristine | 2005 |
Sensitization for anticancer drug-induced apoptosis by betulinic Acid.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Caspases; Cells, Cultured; Cisplatin; Complement Membrane Attack Complex; Complement System Proteins; Cytochromes c; Dactinomycin; Doxorubicin; Drug Synergism; Enzyme Activation; Etoposide; Fibroblasts; Glycoproteins; Humans; Membrane Potentials; Mitochondria; Mutation; Neoplasms; Paclitaxel; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-bcl-2; Triterpenes; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2005 |
[Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dactinomycin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukopenia; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Treatment Outcome; Trophoblastic Tumor, Placental Site; Uterine Neoplasms | 2005 |
[Study on the indication of surgical resection of pulmonary metastasis of malignant trophoblastic tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Hydatidiform Mole, Invasive; Lung; Lung Neoplasms; Methotrexate; Pneumonectomy; Pregnancy; Radiography; Trophoblastic Neoplasms; Uterine Neoplasms | 2005 |
Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Treatment Outcome; Vincristine | 2005 |
Term delivery choriocarcinoma patient with brain and lung metastases successfully treated by etoposide, methotrexate, actomycin D, cyclophosphamide and vincristine (EMA-CO) chemotherapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 2005 |
Correlation of apoptotic potential of simple oxiranes with cytotoxicity.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Cell Count; Cell Line; Cell Survival; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Ethylene Oxide; Etoposide; Fibroblasts; Mice; Oligopeptides | 2006 |
Choriocarcinoma with markedly elevated serum hCG levels and negative urine hCG levels.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Pregnancy; Treatment Outcome; Uterine Neoplasms; Vincristine | 2006 |
Metastatic choriocarcinoma successfully treated with paclitaxel and carboplatin after interstitial lung disease induced by EMA-CO.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Liver Neoplasms; Lung Diseases, Interstitial; Lung Neoplasms; Methotrexate; Paclitaxel; Uterine Neoplasms; Vincristine | 2006 |
Prognostic factors in pleuro-pulmonary blastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Prognosis; Pulmonary Blastoma; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Second-Look Surgery; Treatment Outcome; Vincristine | 2007 |
[Efficacy of FAEV regimen in treatment of high-risk drug-resistant gestational trophoblastic tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Middle Aged; Neoplasm Staging; Pregnancy; Treatment Outcome; Vincristine | 2006 |
[Long-term experiences in the therapy of esthesioneuroblastoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Prognosis; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Time Factors; Vincristine | 2006 |
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
Topics: Adolescent; Anaplasia; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Infant; Infant, Newborn; Kidney; Kidney Neoplasms; Male; Neoplasm Staging; Nephrectomy; Prognosis; Prospective Studies; Radiotherapy; Rhabdoid Tumor; Sarcoma, Clear Cell; Survival Analysis; Vincristine; Wilms Tumor | 2006 |
Uterine choriocarcinoma in a postmenopausal woman.
Topics: Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Postmenopause; Uterine Neoplasms; Vincristine | 2006 |
Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, High-Energy; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome; United States; Vincristine | 2007 |
Recurrent gestational trophoblastic tumor: management and risk factors for recurrence.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Retrospective Studies; Risk Factors; Vincristine | 2006 |
Treatment and prognosis of post term choriocarcinoma in The Netherlands.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Liver Neoplasms; Lung Neoplasms; Methotrexate; Netherlands; Pregnancy; Prognosis; Retrospective Studies; Uterine Neoplasms; Vincristine | 2006 |
[Acquired Fanconi-de Toni-Debre syndrome due to therapy for Ewing's sarcoma in 5-years old boy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child, Preschool; Dactinomycin; Doxorubicin; Etoposide; Fanconi Syndrome; Femur; Humans; Ifosfamide; Male; Sarcoma, Ewing; Vincristine | 2006 |
Cycloheximide protects HepG2 cells from serum withdrawal-induced apoptosis by decreasing p53 and phosphorylated p53 levels.
Topics: Actins; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cycloheximide; Dactinomycin; DNA Fragmentation; Doxorubicin; Etoposide; Flow Cytometry; Humans; Phosphorylation; Protein Synthesis Inhibitors; Reactive Oxygen Species; RNA, Small Interfering; Transfection; Trypan Blue; Tumor Suppressor Protein p53 | 2006 |
Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Incidence; Japan; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Retrospective Studies; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2006 |
Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Illinois; Medical Records; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Neoplasms; Vincristine | 2006 |
Role of surgery in the management of high-risk gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Illinois; Medical Records; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Vincristine | 2006 |
Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Injections, Spinal; Medical Records; Methotrexate; Middle Aged; Neoplasm Metastasis; Philippines; Pregnancy; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Vincristine | 2006 |
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Craniotomy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Staging; Pregnancy; Radiosurgery; Risk Factors; Vincristine | 2007 |
Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Netherlands; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Renal Insufficiency; Treatment Outcome; Vincristine; Wilms Tumor | 2008 |
Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Korea; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Salvage Therapy; Severity of Illness Index; Uterine Neoplasms | 2007 |
Gestational choriocarcinoma: morphological features in a liquid-based endometrial cytological sample.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Doxorubicin; Endometrium; Etoposide; Female; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 2008 |
Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway.
Topics: Animals; Apoptosis; Carrier Proteins; Ceramides; Dactinomycin; Down-Regulation; Enzyme Activation; Etoposide; Gene Expression Regulation, Leukemic; Humans; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; MAP Kinase Kinase Kinase 5; Mice; Oligonucleotide Array Sequence Analysis; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Transport; RNA, Messenger; Thioredoxins; Transcription, Genetic; Up-Regulation | 2008 |
Assessment of the response to chemotherapy in gestational trophoblastic neoplasia with vaginal metastases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Survival Analysis; Vaginal Neoplasms; Vincristine; Young Adult | 2008 |
Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Combined Modality Therapy; Dactinomycin; DNA, Neoplasm; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Iodine Radioisotopes; Male; Neoplasms, Second Primary; Rhabdomyosarcoma, Embryonal; Spinal Neoplasms; Thoracic Vertebrae; Thyroid Neoplasms; Thyroidectomy; Vincristine | 2008 |
Uterine choriocarcinoma accompanied by an extremely high human chorionic gonadotropin level and thyrotoxicosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Thyrotoxicosis; Triiodothyronine; Uterine Neoplasms; Vincristine | 2008 |
Placental site trophoblastic tumor with multiple metastases and complete response to salvage BEP regimen: a case report and review of the literature.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Digestive System Neoplasms; Endocrine Gland Neoplasms; Etoposide; Female; Humans; Hysterectomy; Kidney Neoplasms; Lung Neoplasms; Lymph Node Excision; Methotrexate; Pelvis; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Hemorrhage; Uterine Neoplasms; Vincristine; Young Adult | 2009 |
Chemotherapy for the treatment of children and adolescents with malignant germ cell tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Male; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Risk Assessment; Survival Analysis; Vincristine | 2008 |
Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hungary; Hysterectomy; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Vincristine; Young Adult | 2008 |
Term delivery following successful treatment of choriocarcinoma with brain metastases, a case report and review of literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Craniotomy; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Term Birth; Uterine Neoplasms | 2009 |
Gestational trophoblastic tumor with liver metastasis after misoprostol abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Methotrexate; Misoprostol; Pregnancy; Uterine Neoplasms; Vincristine | 2009 |
Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2008 |
Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.
Topics: Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glomerular Filtration Rate; Humans; Ifosfamide; Infant; Kidney Neoplasms; Kidney Tubules; Linear Models; Male; Nephrectomy; Prospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2009 |
Secondary leukemia in a child conceived using in vitro fertilization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Dactinomycin; Etoposide; Fertilization in Vitro; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Vincristine | 2008 |
[Efficacy of surgical management combined with chemotherapy in the treatment of drug-resistant gestational trophoblastic neoplasm].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Hysterectomy; Lung Neoplasms; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult | 2008 |
Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brazil; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydroxyurea; Methotrexate; Pregnancy; Pregnancy Outcome; Retrospective Studies; Risk Factors; Vincristine | 2009 |
Balloon tamponade of hemorrhage after uterine curettage for gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Catheterization; Dactinomycin; Dilatation and Curettage; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Pregnancy; Uterine Hemorrhage | 2009 |
From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Infant; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Neoplasm Staging; Nephrectomy; Preoperative Care; Retrospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2009 |
Surgical resection in the management of pulmonary metastatic disease of gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Vincristine; Young Adult | 2009 |
Local and systemic control of Ewing's bone sarcoma family tumors of the ribs.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Plates; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fascia Lata; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Ribs; Sarcoma, Ewing; Surgical Mesh; Thoracotomy; Vincristine | 2009 |
Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study.
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Kaplan-Meier Estimate; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Pregnancy; Prognosis; Proportional Hazards Models; Retrospective Studies; ROC Curve; Survival Rate; Treatment Outcome; Trophoblastic Tumor, Placental Site; United Kingdom; Uterine Neoplasms; Vincristine | 2009 |
Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Camptothecin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Etoposide; Fatal Outcome; Female; Foot; Groin; Humans; Ifosfamide; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Lymphatic System; Male; Niacinamide; Phenylurea Compounds; Pyridines; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rhabdomyosarcoma, Alveolar; Salvage Therapy; Soft Tissue Neoplasms; Sorafenib; Temozolomide; Thigh; Vincristine | 2009 |
Changes of mitochondria and relocation of the apoptosis-inducing factor during apoptosis.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Inducing Factor; Cell Nucleus; Chromatin; Cytochromes c; Dactinomycin; DNA Fragmentation; Etoposide; Fluorescent Antibody Technique; HeLa Cells; HSP70 Heat-Shock Proteins; Humans; Microscopy, Confocal; Microscopy, Fluorescence; Mitochondria; Protein Transport; Time Factors | 2009 |
Distribution of centromeric proteins and PARP-1 during mitosis and apoptosis.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Nucleus; Centromere Protein B; Chromosomal Proteins, Non-Histone; Cytoplasm; Dactinomycin; Etoposide; Fluorescent Antibody Technique; HeLa Cells; Humans; Immunohistochemistry; Microfilament Proteins; Microscopy, Confocal; Microscopy, Fluorescence; Mitosis; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Binding | 2009 |
Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; Etoposide; Female; Humans; Hydrocortisone; Injections, Spinal; Male; Meninges; Methotrexate; Myelitis; Neoplasm Invasiveness; Puberty; Radiation Injuries; Retrospective Studies; Rhabdomyosarcoma; Sarcoma, Ewing; Spinal Cord; Spinal Neoplasms; Vincristine | 2009 |
Placental site trophoblastic tumor (PSTT) with multiple metastases and extremely poor prognosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cell Differentiation; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Mitotic Index; Neoplasm Invasiveness; Pregnancy; Tomography, X-Ray Computed; Treatment Failure; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2009 |
Metastasis of gestational trophoblastic neoplasia to the spinal canal: a case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Spinal Canal; Spinal Neoplasms; Uterine Neoplasms; Vincristine; Young Adult | 2009 |
A rare case of simultaneous occurrence of Wilms' tumor in the left kidney and the bladder.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Infant; Kidney Neoplasms; Male; Neoplasms, Multiple Primary; Ultrasonography; Urinary Bladder Neoplasms; Vincristine; Wilms Tumor | 2010 |
Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiotherapy; Sarcoma; Treatment Outcome; Vincristine | 2010 |
Good prognosis for primary ovarian pure nongestational choriocarcinoma using the EMA/CO regime.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma, Non-gestational; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Ovarian Neoplasms; Prognosis; Vincristine; Young Adult | 2010 |
Macrophage response to apoptotic cells varies with the apoptotic trigger and is not altered by a deficiency in LRP expression.
Topics: Amino Acid Chloromethyl Ketones; Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase Inhibitors; Dactinomycin; Etoposide; HeLa Cells; Humans; Jurkat Cells; LDL-Receptor Related Proteins; Lipopolysaccharides; Macrophages; Mice; Mice, Knockout; Phagocytosis; Promoter Regions, Genetic; Quinolines; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2010 |
A case of uterine pseudoaneurysm combined with gestational trophoblastic disease in a 30-year-old woman.
Topics: Adult; Aneurysm, False; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Dilatation and Curettage; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Trophoblastic Neoplasms; Ultrasonography, Doppler; Uterine Artery; Uterine Artery Embolization; Vincristine | 2011 |
Knockdown of sensitive to apoptosis gene by small interfering RNA enhances the sensitivity of PC3 cells toward actinomycin D and etoposide.
Topics: Apoptosis; Cell Line, Tumor; Dactinomycin; Etoposide; Free Radical Scavengers; Gene Knockdown Techniques; Humans; Oxidation-Reduction; Reactive Oxygen Species; RNA, Small Interfering; Ubiquitin-Protein Ligases | 2010 |
Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Choroid Neoplasms; Dactinomycin; Etoposide; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2010 |
Infratentorial brain metastases of pediatric non-epithelial malignant tumors: three case reports.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Infratentorial Neoplasms; Irinotecan; Melphalan; Neoplasm Metastasis; Neuroblastoma; Rhabdomyosarcoma; Thiotepa; Topotecan; Vincristine | 2011 |
Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2011 |
Metastatic placental site trophoblastic tumour successfully treated with hysterectomy and EMA/CO chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2011 |
Characterisation of transient benign hCG elevations in women following chemotherapy for GTT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Estradiol; Etoposide; Female; Follicle Stimulating Hormone; Gestational Trophoblastic Disease; Humans; Ifosfamide; Leucovorin; Luteinizing Hormone; Methotrexate; Pregnancy; Retrospective Studies; Taxoids; Vincristine; Young Adult | 2011 |
Ovarian involvement of epithelioid trophoblastic tumor: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Immunohistochemistry; Methotrexate; Neoplasms, Second Primary; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 2011 |
Apoptosis induced clustering of IP(3)R1 in nuclei of non-differentiated PC12 cells.
Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; bcl-2-Associated X Protein; Boron Compounds; Calcium; Camptothecin; Caspase 3; Cell Differentiation; Cell Nucleus; Cycloheximide; Dactinomycin; Dexamethasone; Etoposide; Inositol 1,4,5-Trisphosphate Receptors; PC12 Cells; Permeability; Rats; RNA, Messenger; Time Factors; Up-Regulation | 2011 |
Inhibition of unwinding and ATPase activities of pea MCM6 DNA helicase by actinomycin and nogalamycin.
Topics: Adenosine Triphosphatases; Camptothecin; Cisplatin; Dactinomycin; Daunorubicin; DNA Helicases; Ellipticines; Enzyme Inhibitors; Etoposide; Intercalating Agents; Mitoxantrone; Nogalamycin; Novobiocin; Pisum sativum; Plant Proteins | 2011 |
Role of p53 serine 46 in p53 target gene regulation.
Topics: Binding Sites; Cell Line, Tumor; Chromatin; Chromatin Immunoprecipitation; Cluster Analysis; Dactinomycin; DNA; Etoposide; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Molecular Sequence Annotation; Phosphorylation; Phosphoserine; Protein Binding; Sequence Analysis, Protein; Serine; Structure-Activity Relationship; Tumor Suppressor Protein p53 | 2011 |
Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prognosis; Republic of Korea; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2011 |
[Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].
Topics: 12E7 Antigen; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Calmodulin-Binding Proteins; Cell Adhesion Molecules; Chemotherapy, Adjuvant; Combined Modality Therapy; Dactinomycin; Disease Management; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Neoplasm Proteins; Reoperation; RNA-Binding Protein EWS; RNA-Binding Proteins; Sarcoma, Ewing; Shoulder; Skin Neoplasms; Vincristine; Young Adult | 2011 |
Metastatic choriocarcinoma presenting and treated during viable pregnancy: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prenatal Diagnosis; Tomography, X-Ray Computed; Uterine Neoplasms; Vincristine | 2011 |
Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Disease Progression; Etoposide; Female; Gestational Trophoblastic Disease; Humans; India; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2011 |
Choriocarcinoma of the sigmoid colon: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Colon, Sigmoid; Colonoscopy; Dactinomycin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Grading; Neoplasm Staging; Sigmoid Neoplasms | 2012 |
Pediatric clear cell sarcoma of the kidney with cavoatrial thrombus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cardiopulmonary Bypass; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Doxorubicin; Etoposide; Heart Atria; Hepatic Veins; Humans; Kidney Neoplasms; Male; Neoadjuvant Therapy; Nephrectomy; Sarcoma, Clear Cell; Thrombectomy; Tomography, X-Ray Computed; Ultrasonography; Vena Cava, Inferior; Venous Thrombosis; Vincristine; Wilms Tumor | 2011 |
Teratoid Wilms' tumor: case report of a rare variant that can mimic aggressive biology during chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Nephrectomy; Prognosis; Stromal Cells; Vincristine; Wilms Tumor | 2011 |
Conservative treatment and long-term follow up of endodermal sinus tumor of the vagina.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Endodermal Sinus Tumor; Etoposide; Female; Fertility Preservation; Follow-Up Studies; Humans; Infant; Neoplasm Staging; Treatment Outcome; Vaginal Neoplasms; Vincristine | 2012 |
Minimally-aggressive gestational trophoblastic neoplasms.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Treatment Outcome; Vincristine | 2012 |
Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Cell Line, Tumor; Cell Membrane; Dactinomycin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fenretinide; Fluoresceins; Fluorescent Dyes; Gene Expression; HSP70 Heat-Shock Proteins; Humans; Membrane Proteins; Mitochondria; Protein Transport; Sarcoma, Ewing; Vincristine | 2012 |
The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Half-Life; Humans; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Uterine Neoplasms; Vincristine; Young Adult | 2012 |
Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Incidence; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2012 |
Choriocarcinoma of the lung masquerading as a persisting pregnancy of unknown location (PUL).
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Etoposide; False Positive Reactions; Female; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Pregnancy; Radiography; Treatment Outcome; Vincristine; Vitamin B Complex | 2012 |
Apoptotic cells can deliver chemotherapeutics to engulfing macrophages and suppress inflammatory cytokine production.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Communication; Cell Line; Coculture Techniques; Cytokines; Dactinomycin; Etoposide; Flow Cytometry; Humans; Inflammation Mediators; Jurkat Cells; Lipopolysaccharides; Macrophages; Phagocytosis; Tumor Necrosis Factor-alpha | 2012 |
Intracellular distribution of Tankyrases as detected by multicolor immunofluorescence techniques.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Dactinomycin; Endoplasmic Reticulum; Etoposide; Golgi Apparatus; HeLa Cells; Humans; Interphase; Protein Transport; Tankyrases; Telomerase; Telomere | 2012 |
Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancer.
Topics: Antineoplastic Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; bcl-X Protein; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Antagonism; Drug Synergism; Etoposide; Humans; Immunoblotting; Lung Neoplasms; Paclitaxel; Protein Kinase C; Signal Transduction; Staurosporine; Time Factors | 2012 |
EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Retrospective Studies; Uterine Neoplasms; Young Adult | 2012 |
Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Vincristine | 2012 |
Comparison of methotrexate, actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia.
Topics: Adult; Alopecia; Antineoplastic Agents; Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Nausea; Pregnancy; Prospective Studies; Remission Induction; Stomatitis; Vitamin B Complex; Vomiting; Young Adult | 2012 |
Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Choriocarcinoma; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Guideline Adherence; Humans; Hydatidiform Mole; Hysterectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Netherlands; Practice Guidelines as Topic; Pregnancy; Retrospective Studies; Risk Assessment; Treatment Outcome; Uterine Neoplasms; Vincristine | 2012 |
Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Doxorubicin; Etoposide; Female; Hamartoma; Humans; Ifosfamide; Liver Neoplasms; Mesoderm; Prognosis; Sarcoma, Ewing; Vincristine; Young Adult | 2013 |
Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cryopreservation; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Fertility Preservation; Follicle Stimulating Hormone; Humans; Ifosfamide; Ovary; Primary Ovarian Insufficiency; Prognosis; Puberty; Radiotherapy, Conformal; Sarcoma, Ewing; Vincristine | 2013 |
Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Netherlands; Pregnancy; Prognosis; Remission Induction; Risk Factors; Survival Rate; Vincristine | 2013 |
Real-time cell viability assays using a new anthracycline derivative DRAQ7®.
Topics: Anthracyclines; Apoptosis; Benzamides; Biphenyl Compounds; Cell Line, Tumor; Cell Survival; Dactinomycin; DNA Damage; Etoposide; Flow Cytometry; Fluorescent Dyes; Histones; Humans; Inhibitory Concentration 50; Membrane Potential, Mitochondrial; Nitrophenols; Piperazines; Rhodamines; Staurosporine; Sulfonamides; Sulfones | 2013 |
EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2013 |
Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
Topics: Adult; Anti-Mullerian Hormone; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Dactinomycin; Dilatation and Curettage; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Ovary; Pregnancy; Young Adult | 2013 |
Pure nongestational choriocarcinoma of the ovary: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma, Non-gestational; Combined Modality Therapy; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Ovarian Neoplasms; Prognosis | 2013 |
Activation of p53 by chemotherapeutic agents enhances reovirus oncolysis.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Combined Modality Therapy; Cyclin-Dependent Kinase Inhibitor p21; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; NF-kappa B; Oncolytic Viruses; Reoviridae; Tumor Suppressor Protein p53 | 2013 |
Unsuspected metastatic choriocarcinoma presenting as unexplained severe anaemia.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Neoplasm Metastasis; Pregnancy; Uterine Neoplasms; Vincristine | 2013 |
High-dose chemotherapy with autologous stem cell support as salvage therapy in recurrent gestational trophoblastic disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Vincristine | 2013 |
Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; India; Methotrexate; Middle Aged; Pregnancy; Salvage Therapy; Survival Analysis; Tertiary Care Centers; Treatment Outcome; Vincristine; Young Adult | 2014 |
[A case of a nonseminomatous germ cell tumor responding to MEA therapy].
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2013 |
All children with malignant rhabdoid tumors should be treated initially with intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Mediastinal Neoplasms; Rhabdoid Tumor; Tomography, X-Ray Computed; Vincristine | 2015 |
After the treated mole.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Immunophenotyping; Leukemia, Myeloid, Acute; Methotrexate; Neoplasms, Second Primary; Pregnancy; Trophoblasts; Vincristine | 2014 |
Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Remission Induction; Survival Analysis; Young Adult | 2014 |
Combination chemotherapy regimen with floxuridine, dactinomycin, etoposide, and vincristine as primary treatment for gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult | 2014 |
Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Testicular Neoplasms; Vincristine | 2017 |
[Unusual antenatal gestational choriocarcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Dactinomycin; Etoposide; Female; Gestational Age; Humans; Male; Methotrexate; Pregnancy; Pregnancy Outcome; Prognosis; Seizures; Tomography, X-Ray Computed; Uterine Neoplasms | 2014 |
Attempted conservative management of a placental site trophoblastic tumor: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lymph Node Excision; Methotrexate; Paclitaxel; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2014 |
Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Salvage Therapy; Survival Rate; Uterine Neoplasms; Vaginal Neoplasms; Vincristine; Young Adult | 2015 |
Children with relapsed or refractory nephroblastoma: favorable long-term survival after high-dose chemotherapy and autologous stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Transplantation Conditioning; Vincristine; Wilms Tumor | 2014 |
Resistance to single-agent chemotherapy and its risk factors in low-risk gestational trophoblastic neoplasms.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Iran; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Vincristine; Young Adult | 2015 |
Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Incidence; Kaplan-Meier Estimate; Menopause, Premature; Methotrexate; Middle Aged; Neoplasms, Second Primary; Odds Ratio; Pregnancy; Risk Assessment; Risk Factors; Uterine Neoplasms; Vincristine; Young Adult | 2015 |
Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leukocyte Count; Male; Neoadjuvant Therapy; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine | 2015 |
Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma, Non-gestational; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Middle Aged; Pregnancy; Treatment Outcome; Vincristine; Young Adult | 2015 |
Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Obesity; Overweight; Pregnancy; Prognosis; Remission Induction; Vincristine; Young Adult | 2015 |
Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital.
Topics: Adult; Brain Neoplasms; China; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Risk Factors; Vincristine | 2015 |
Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asian; Black or African American; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Risk Factors; White People; Young Adult | 2015 |
5-Lipoxygenase is a direct p53 target gene in humans.
Topics: Arachidonate 5-Lipoxygenase; Binding Sites; Dactinomycin; DNA Damage; Etoposide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HCT116 Cells; HEK293 Cells; HeLa Cells; Humans; Promoter Regions, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2015 |
A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Treatment Outcome; Vincristine; Young Adult | 2016 |
Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Nomograms; Pregnancy; Prognosis; Regression Analysis; ROC Curve; Vincristine; Young Adult | 2015 |
The Role of Computed Tomography Scanning of the Thorax in the Initial Assessment of Gestational Trophoblastic Neoplasia.
Topics: Administration, Intravenous; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Neoplasm Staging; Pregnancy; Radiography, Thoracic; Risk Assessment; Salvage Therapy; Tomography, X-Ray Computed | 2015 |
Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertility Preservation; Follow-Up Studies; Humans; Hysterectomy; Neoplasm Grading; Neoplasm Staging; Organ Sparing Treatments; Ovarian Neoplasms; Ovariectomy; Pregnancy; Pregnancy Rate; Retrospective Studies; Salpingectomy; Survival Rate; Teratoma; Vincristine; Young Adult | 2015 |
PARP Inhibitors Sensitize Ewing Sarcoma Cells to Temozolomide-Induced Apoptosis via the Mitochondrial Pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Dacarbazine; Dactinomycin; Doxorubicin; Drug Synergism; Etoposide; G2 Phase Cell Cycle Checkpoints; Humans; Ifosfamide; Metabolic Networks and Pathways; Mitochondria; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Sarcoma, Ewing; Temozolomide; Vincristine | 2015 |
Secondary Hemophagocytic Lymphohistiocytosis in a Patient With Favorable Histology Wilms Tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Dactinomycin; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Immunoglobulins, Intravenous; Kidney Neoplasms; Lung Neoplasms; Lymphohistiocytosis, Hemophagocytic; Neoadjuvant Therapy; Nephrectomy; Remission Induction; Vincristine; Wilms Tumor | 2015 |
Conservative Chemotherapy in Gestational Trophoblastic Disease: Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Pregnancy; Prognosis; Salvage Therapy | 2016 |
Primary mediastinal choriocarcinoma with brain metastasis in a female patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma, Non-gestational; Cyclophosphamide; Dactinomycin; Etoposide; Fatal Outcome; Female; Humans; Mediastinal Neoplasms; Methotrexate; Middle Aged; Vincristine | 2016 |
Etoposide-Actinomycin as Salvage Regimen for the Treatment of Nonmetastatic and Low-Risk Metastatic Gestational Trophoblastic Neoplasia: Experience at the Philippine General Hospital.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Pregnancy; Retrospective Studies; Risk Factors; Salvage Therapy | 2016 |
Spontaneous renal hemorrhage caused by invasive mole: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Etoposide; Female; Hemorrhage; Humans; Hydatidiform Mole, Invasive; Kidney Diseases; Leucovorin; Methotrexate; Pregnancy; Uterine Neoplasms; Vincristine | 2016 |
Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Fertility Preservation; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Middle Aged; Pregnancy; Prognosis; Term Birth; Treatment Outcome; Uterine Neoplasms; Young Adult | 2016 |
Primary treatment of stage IV gestational trophoblastic neoplasia with floxuridine, dactinomycin, etoposide and vincristine (FAEV): A report based on our 10-year clinical experiences.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Neoplasm Staging; Pregnancy; Vincristine | 2016 |
Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brazil; Case-Control Studies; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Leucovorin; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Vacuum Curettage; Vincristine; Watchful Waiting; Young Adult | 2016 |
Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Transitional Cell; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Deoxycytidine; Doxorubicin; Etoposide; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pelvic Neoplasms; Remission Induction; Ureteral Neoplasms | 2017 |
Gestational choriocarcinoma with renal and pulmonary metastases lacking a primary uterine origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Hematuria; Humans; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Methotrexate; Neoplasms, Unknown Primary; Pregnancy; Vincristine | 2016 |
The added value of hysterectomy in the management of gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult | 2017 |
Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Prognosis; Retrospective Studies; Risk Factors; Salvage Therapy; Vincristine; Young Adult | 2017 |
Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Kaplan-Meier Estimate; Medical Futility; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors; Salvage Therapy; Vincristine; Young Adult | 2017 |
Role of chemotherapy and thrombolysis in treatment of choriocarcinoma accompanied with pulmonary embolism: A case report with literature review.
Topics: Adult; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pulmonary Embolism; Uterine Neoplasms; Vincristine | 2017 |
Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Infant, Newborn; Italy; Male; Methotrexate; Multicenter Studies as Topic; Pregnancy; Pregnancy Outcome; Retrospective Studies; Vincristine; Young Adult | 2018 |
Investigating the potential impact of dose banding for systemic anti-cancer therapy in the paediatric setting based on pharmacokinetic evidence.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Area Under Curve; Busulfan; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Drug Dosage Calculations; Drug Monitoring; Etoposide; Humans; Infant; Models, Biological; Neoplasms; Patient Safety; Risk Factors | 2018 |
Nucleolar TRF2 attenuated nucleolus stress-induced HCC cell-cycle arrest by altering rRNA synthesis.
Topics: Amino Acid Sequence; Antineoplastic Agents; Camptothecin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Nucleolus; Cell Proliferation; Dactinomycin; Etoposide; Gene Expression Regulation, Neoplastic; HEK293 Cells; Hep G2 Cells; Humans; Nuclear Proteins; Phosphoproteins; Protein Binding; Protein Transport; Ribosomes; RNA, Ribosomal; RNA, Small Interfering; Signal Transduction; Telomeric Repeat Binding Protein 2 | 2018 |
Successful treatment of multisite hemorrhage by several methods in brain metastasis of choriocarcinoma: A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Brain; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Hemorrhage; Hemostatic Techniques; Humans; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Tomography, X-Ray Computed; Uterine Neoplasms; Vincristine | 2018 |
Is there uniformity in definitions and treatment of gestational trophoblastic disease in Europe?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Europe; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Vincristine | 2019 |
Genotoxic stress increases cytoplasmic mitochondrial DNA editing by human APOBEC3 mutator enzymes at a single cell level.
Topics: Animals; APOBEC Deaminases; CD4-Positive T-Lymphocytes; Cells, Cultured; Cytidine Deaminase; Cytosol; Dactinomycin; DNA Damage; DNA, Mitochondrial; Etoposide; Fibroblasts; Humans; Mitochondria; Quail; Single-Cell Analysis | 2019 |
Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carboplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Substitution; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Extra-Adrenal Adult Neuroblastoma With Aberrant Germ Cell Marker Expression: Maturation After Chemotherapy as an Important Clue to a Challenging Diagnosis.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Etoposide; Germ Cells; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Humans; Ifosfamide; Inguinal Canal; Male; Neuroblastoma; Nuclear Proteins; Octamer Transcription Factor-3; Transcription Factors; Vincristine | 2019 |
ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Bone Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dactinomycin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; HEK293 Cells; Hep G2 Cells; Humans; MCF-7 Cells; Neoplastic Stem Cells; Osteosarcoma; RNA, Messenger; Vincristine | 2019 |
Paternal uniparental isodisomy of tyrosine hydroxylase locus at chromosome 11p15.4: spectrum of phenotypical presentations simulating hydatidiform moles.
Topics: Abortion, Missed; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosomes, Human, Pair 11; Cyclophosphamide; Dactinomycin; Etoposide; Female; Genetic Loci; Genetic Predisposition to Disease; Humans; Hydatidiform Mole; Male; Methotrexate; Phenotype; Pregnancy; Treatment Outcome; Tyrosine 3-Monooxygenase; Uniparental Disomy; Uterine Neoplasms; Vincristine | 2019 |
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Dactinomycin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Methotrexate; Polymorphism, Single Nucleotide | 2019 |
Genetically Related Choriocarcinoma Developing 5 Yr After a Complete Hydatidiform Mole and Simulating a Cornual Ectopic Pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Female; Genotype; Genotyping Techniques; Humans; Hydatidiform Mole; Methotrexate; Pregnancy; Pregnancy, Ectopic; Uterine Neoplasms; Vincristine | 2020 |
Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Prospective Studies; Rhabdomyosarcoma; Survival Rate; Vincristine; Young Adult | 2019 |
Metastatic Brain Choriocarcinoma in a Postmenopausal Woman: A Case Report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Postmenopause; Uterine Neoplasms; Vincristine | 2020 |
EMA vs EMACO in the treatment of gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dactinomycin; Doxorubicin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Mitoxantrone; Multivariate Analysis; Neoplasm Staging; Pregnancy; Retrospective Studies; Vincristine | 2020 |
Epithelioid Hyalinizing Sarcoma With MGA-NUTM1 Fusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Cyclophosphamide; Dactinomycin; Etoposide; Foot; Foot Bones; Gene Fusion; Humans; Hyalin; Ifosfamide; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Nuclear Proteins; Organophosphorus Compounds; Sarcoma; Vincristine | 2020 |
M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Risk Factors; Vincristine | 2021 |
Management and prognostic analysis of patients with gestational trophoblastic neoplasia (GTN) in FIGO stage IV and its special type.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Disease Management; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Survival Rate; Vincristine | 2021 |
Placental site trophoblastic tumour: five challenges of patient clinical management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cisplatin; Consolidation Chemotherapy; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Lung Neoplasms; Lymph Node Excision; Methotrexate; Paclitaxel; Pregnancy; Puerperal Disorders; Salpingectomy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms | 2021 |
Uterine Rescue in High-Risk Gestational Trophoblastic Neoplasia Treated with EMA-CO by Uterine Arteries Embolization due to Arteriovenous Malformations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arteriovenous Malformations; Cyclophosphamide; Dactinomycin; Embolization, Therapeutic; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy, High-Risk; Ultrasonography, Prenatal; Uterine Artery; Uterine Hemorrhage; Vincristine; Young Adult | 2021 |
Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
Topics: Adolescent; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; France; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hysterectomy; Leucovorin; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine; Young Adult | 2021 |
Choriocarcinoma brain metastasis in a patient in the third trimester: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Pregnancy; Pregnancy Trimester, Third; Uterine Neoplasms; Vincristine | 2021 |
Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5.
Topics: Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Obstetrics; Pregnancy; Vincristine | 2021 |
Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Vincristine; Wilms Tumor | 2022 |
Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report.
Topics: Brain Neoplasms; Choriocarcinoma; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Placenta; Pregnancy; Trophoblastic Neoplasms | 2022 |
EMACO for treatment of gestational trophoblastic neoplasia: A multinational multicenter study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Vincristine | 2023 |